POPULARITY
13 episodes with healio
13 episodes with healio
11 episodes with healio
10 episodes with healio
8 episodes with healio
3 episodes with healio
4 episodes with healio
2 episodes with healio
2 episodes with healio
“If you read this book on a Friday, we promise you will be better at your job on Monday.” In the high-stakes environment of the Emergency Department, we often focus on the “big saves,” but what if the secret to a thriving career lies in the tiny details? In part one of this special two-part series, we sit down with Dr. Resa Lewiss, an emergency and lifestyle medicine physician, TEDMED speaker, and co-author of the hit book Micro Skills: Small Actions, Big Impact. We dive into why the “workplace playbook” isn’t always handed to us and how breaking down overwhelming professional goals into small, actionable behaviors can transform your trajectory. What Exactly Are “Micro Skills”? Dr. Lewiss defines Micro Skills as the small, actionable behaviors and steps that serve as the building blocks for achieving massive goals. Whether it's tackling an overwhelming project or building a habit you thought was “just for other people,” almost everything can be broken down into these manageable units. For Dr. Lewiss and her co-author, Dr. Adaira Landry, these skills are the “missing playbook” they wish they'd had earlier in their careers. Early Career: The Micro Skills of Self-Care For those just entering the workforce—from residents to new attendings—the focus must be on sustainability. Become an “Award-Winning Sleeper”: Stop wearing exhaustion as a badge of honor. Dr. Lewiss highlights why sleep is a professional necessity, not a luxury. The Personal Board of Directors: Create a “round table” of go-to people—mentors, peers, and sponsors—who can help you navigate professional and personal hurdles. Mid-Career: Navigating Conflict & Team Dynamics As physicians gain competence and move into leadership, the challenges become more interpersonal. The “Paper Tiger” Colleague: Learn how to identify coworkers who project authority they don't actually have by trusting your “Spidey sense”, checking organizational charts, asking established leadership. Inquiring Carefully: When navigating workplace tension, focus on avoiding gossip and seeking clarity from trusted supervisors. Late Career: Modeling Culture & Professionalism Seasoned physicians have the greatest power to shift the culture of a department. The Scheduled Send: Protect your team's “deliberate rest” by scheduling emails to arrive during standard business hours. From Bystander to Upstander: Use your seniority to shut down unprofessional behavior with simple scripts like, “I don't understand the joke, can you explain it to me?” Coming Up in Part 2… The conversation continues! In the next episode, we explore the “Power of the Pause,” why Dr. Lewiss advocates for the “Joy of Missing Out” (JOMO), and a simple three-question framework (Start, Stop, Continue) to get the meaningful feedback you actually need to grow. We want to hear from you! Which of these micro skills resonated with you? Have you been able to apply these to your daily life and medical practice? Connect with us on social media @empulsepodcast or on our website ucdavisem.com. Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Professor of Emergency Medicine at UC Davis Guest: Dr. Resa E. Lewiss, Emergency Medicine and Lifestyle Medicine Physician, Adjunct Professor of Emergency Medicine at the Warren Alpert Medical School of Brown University, TEDMED speaker, educator and mentor. Resources: Micro Skills: Small Actions, Big Impact, by Adaira Landry, MD and Resa E. Lewiss, MD The Visible Voices Podcast, hosted by Dr. Resa Lewiss Lewiss on Lifestyle Medicine, column on Healio by Dr. Resa Lewiss *** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.
This special edition episode features the latest installment of Healio Community's book club. Physician author Kevin J. Tracey, MD, discussed his book, The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes in which he explores the potential of stimulating the vagus nerve to treat rheumatoid arthritis and other diseases. · Intro by Adam J. Brown, MD 0:14 · A warm welcome from Leonard H. Calabrese, DO 0:25 · Introducing Kevin J. Tracey, MD 0:58 · The connection between the brain and the immune system 3:25 · Where was the switch that combined neural networks and immune response? 5:55 · A brief summary of the main parts of The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes 9:18 · The science of vagal nerve stimulation 11:03 · What are the pros and cons of different strategies of stimulating the vagus nerve? 16:28 · Different inflammatory responses to implant devices 17:35 · Data on vagus nerve stimulation 21:38 · Adopting new technology 25:40 · Enhancing immune health through brain health 28:35 · Wellness behaviors 32:55 · A motivated patient 36:16 · Thank you, Dr. Tracey 38:03 · Thanks for listening 39:26 Don't miss out! To engage in future conversations like this with physician authors on Healio Community, register here. We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.
In this special podcast episode, Gut Talk host Sameer Berry, MD, interviews his co-host William Chey, MD, to look back at the lessons learned throughout the milestones in his career, and discuss what lies ahead for his year as ACG president. · Intro 1:11 · Looking back, are there Gut Talk episodes that stand out to you as being particularly memorable? 1:55 · Berry and Chey on common themes in past episodes. 4:46 · Where did you grow up and what were your childhood/early adult years like? 9:19 · Do you think your father being a division chief inspired you? 14:01 · Were there other times your father influenced you? 15:10 · Tell us more about the decisions you have made throughout your training […] Were there other influences that still guide you today? 16:58 · Are there lessons that your mentors left you with in terms of how to be a leader and think creatively? 19:50 · What about guidance you have given as a mentor? […] What advice would you give to those who want to have a leadership career within academics in today's climate? 22:10 · What does the honor of being ACG president mean to you? How did your involvement with the ACG come to be? 26:58 · What does the day-to-day look like as president of the college, and what are some of the key initiatives you are going to work on this year? 30:29 · What are some of the things that excite you most for the future of the college, the GI specialty and the health care industry? 34:26 · Thank you, Bill 37:33 · Thanks for listening 37:55 William D. Chey, MD, AGAF, FACG, is chief and professor in the division of gastroenterology and hepatology at the University of Michigan, where he leads research on diet and nutrition and their impact on functional bowel disorders. He is also co-host of Healio's Gut Talk podcast. Chey is the president of the American College of Gastroenterology (ACG) for the 2025–2026 term. We'd love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. Disclosures: Berry and Chey report no financial disclosures.
In this special episode of Eyeluminaries, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Hawaiian Eye 2026, with guest Peter N. Slack, president and CEO of the Wyanoke Group, who was honored with the annual Lindstrom Leadership Award and Lecture . Welcome to Eyeluminaries 00:42 Hawaiian Eye 2026 – Peter Slack receives the Lindstrom Leadership Award 01:08 Intro of Peter Slack 02:42 What is the history of OSN and your involvement of the company? 04:09 The philosophy of the editorial board 06:41 Lindstrom Leadership Award/ Longevity of employees 08:43 Healio meetings and lifelong friends 10:58 Healio meetings and golf 12:40 Sunshine Eye 14:18 Thank you, Peter Slack and congratulations! 16:29 Check out Healio AI 17:02 Thank you! 18:00 Peter N. Slack, is the president and CEO of the Wyanoke Group. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X @DrHovanesian.
Matt Holland is Chief Operating Officer at Healio, a company that has been producing high-quality, vetted information for healthcare professionals for over 100 years. The company has focused on personalization of data as it has evolved from print to digital to AI-driven access to on-demand information. Healio AI is also transforming continuing medical education from a static activity to a dynamic, personalized experience based on real-time information gaps. Matt explains, "We're a little bit unique in this space. We're family-owned and privately held, and have been for over a hundred years. So there are a lot of companies in this market right now that are not. So for decades, the focus has really been on developing and delivering quality information to healthcare professionals through all sorts of different channels. Obviously, prior to the internet, it started with good publications and journals. We also have a series of live meetings and conferences, but the primary focus really is the Healio AI, which we launched and evolved, and have been evolving, I should say, for the past 13 years or so." "We just announced the Physician Advisory Board the other day. We just announced that physicians can get credit for CME and CV credits for their searches. And the reason why I mention that is physicians are no longer looking to necessarily read a full article or go into a deep dive on a particular topic. They're looking for an answer to a question they may have either prior to the point of care, during the point of care, or after. And we all know that their time is precious, and obviously, the issue of burnout is pretty pervasive. So, our goal is really to help make their lives simpler and improve the quality of their practice and the delivery of the care that they provide." "We are a publishing news organization, and every day we develop 50-60 pieces of content from the FDA or from conferences or new studies that were released, and that's going into our model every 24 hours. So, there's sort of a deep dive substantive piece with the peer-reviewed and the journal content. There's a recency component to it with our news that goes into it, which makes the Healio AI a little bit different and we think unique, and I think balances and then hopefully more accurately and quickly addresses the questions that healthcare professionals have." #Healio #HealioAI #DigitalHealth #HealthcareAI #GenAI #MedicalTechnology #HealthcareProfessionals #CME #PointOfCare #MedicalInformation #HealthTech #PhysicianBurnout #ContinuingEducation #HealthcareInnovation #MedicalJournalism #AIinHealthcare Healio.com Download the transcript here
Matt Holland is Chief Operating Officer at Healio, a company that has been producing high-quality, vetted information for healthcare professionals for over 100 years. The company has focused on personalization of data as it has evolved from print to digital to AI-driven access to on-demand information. Healio AI is also transforming continuing medical education from a static activity to a dynamic, personalized experience based on real-time information gaps. Matt explains, "We're a little bit unique in this space. We're family-owned and privately held, and have been for over a hundred years. So there are a lot of companies in this market right now that are not. So for decades, the focus has really been on developing and delivering quality information to healthcare professionals through all sorts of different channels. Obviously, prior to the internet, it started with good publications and journals. We also have a series of live meetings and conferences, but the primary focus really is the Healio AI, which we launched and evolved, and have been evolving, I should say, for the past 13 years or so." "We just announced the Physician Advisory Board the other day. We just announced that physicians can get credit for CME and CV credits for their searches. And the reason why I mention that is physicians are no longer looking to necessarily read a full article or go into a deep dive on a particular topic. They're looking for an answer to a question they may have either prior to the point of care, during the point of care, or after. And we all know that their time is precious, and obviously, the issue of burnout is pretty pervasive. So, our goal is really to help make their lives simpler and improve the quality of their practice and the delivery of the care that they provide." "We are a publishing news organization, and every day we develop 50-60 pieces of content from the FDA or from conferences or new studies that were released, and that's going into our model every 24 hours. So, there's sort of a deep dive substantive piece with the peer-reviewed and the journal content. There's a recency component to it with our news that goes into it, which makes the Healio AI a little bit different and we think unique, and I think balances and then hopefully more accurately and quickly addresses the questions that healthcare professionals have." #Healio #HealioAI #DigitalHealth #HealthcareAI #GenAI #MedicalTechnology #HealthcareProfessionals #CME #PointOfCare #MedicalInformation #HealthTech #PhysicianBurnout #ContinuingEducation #HealthcareInnovation #MedicalJournalism #AIinHealthcare Healio.com Listen to the podcast here
In this throwback episode honoring National Women Physicians Day, host Shikha Jain, MD, with Physicianary's Hansa Bhargava, MD, and Mend the Gap's Dagny Zhu, MD, discuss the evolution of empowering yourself and others and advocacy with a panel of guests. · Intro 0:32 · What does it mean to empower women in medicine, and what are the ways that we can really empower others to achieve the things that they may not see for themselves? 1:37 · What are some ways in which you have empowered or hope to empower women in medicine? Are there tips or skills that have worked well? 4:41 · How have you been empowered by others, or have helped others find their voices? 7:37 · Do you agree that the conversation is changing toward a cultural shift in empowerment for women in health care? 12:23 · What are some challenges facing advocacy and empowerment? […] What do you do when your advocacy work is not being received or it is a struggle to speak up for someone? 17:10 · Emphasizing the importance of communication in advocacy work. 22:23 · Intro to Physicianary's part 3 on physician burnout and work-life balance. 22:51 · Thanks for listening 23:31 Be sure to listen to Part 1 and Part 3 of Healio's Women In Medicine roundtable discussion, streaming everywhere now! Vineet Arora, MD, MAPP (NAM), is a Herbert T. Abelson professor of medicine, vice dean of education in the biological sciences division and dean for medical education at the University of Chicago Pritzker School of Medicine. She is also an elected member of the National Academy of Medicine. She is a founding member of the 501c3 Women of Impact and advisor to the Women in Medicine Summit. Jennifer Bepple, MD, MMCi, is a double board-certified physician in urology and informatics. She is a member of the American Telemedicine Association, American Urologic Association and American Medical Informatics Association and holds a certification from the American Board of Telehealth and the American Board of AI in Medicine. Hansa Bhargava, MD, is Healio's chief clinical strategy and innovation officer. Listen to her Healio podcast, Physicianary. Shikha Jain, MD, FACP, is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the division of hematology and oncology, the director of communication strategies in medicine and the associate director of oncology communication & digital innovation at the University of Illinois Cancer Center in Chicago. Mara Schenker, MD, FACS, FAOA, is an orthopedic trauma surgeon at Grady Memorial Hospital. She is double board certified in orthopedic surgery and clinical informatics. She serves as the chief of orthopedics and associate chief medical information officer. She is an associate professor of orthopedics at Emory University School of Medicine. She serves on multiple boards for medical and digital technology advisory and sits on major national committees for the American Academy of Orthopaedic Surgeons, AAMC, American College of Surgeons and the Orthopaedic Trauma Association. Dagny Zhu, MD, is a cornea, cataract and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. She can be reached on X @DZEyeMD. Listen to her on Healio's Mend The Gap: Equity In Medicine podcast. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Disclosures: The hosts and guests report no relevant financial disclosures.
To celebrate 101 episodes, I sit with Leonard H. Calabrese, DO, to discuss his unique career in Rheumatology, spanning immunology, HIV, MECFS, IRES, CNS vasculitis and more. We also discuss how medical history shaped our careers. · Intro 0:12 · Welcome Leonard H. Calabrese, DO 3:11 · A quick friendship begins over medical history 4:14 · How Healio Rheuminations began and where the show is now 5:38 · How Dr. Calabrese got interested in medical history 7:11 · Serotherapy 10:52 · Why patients get certain diseases 12:33 · Dr. Calabrese's career trajectory 14:43 · One day in 1981… 17:52 · A few things happened in the 90's 20:20 · Tell us about CNS vasculitis 21:53 · Don't be afraid to reinvent yourself 24:30 · Checkpoint inhibitors 25:09 · How do you keep up? 26:43 · Placebo science 28:25 · Do you think we'll ever be able to answer where diseases come from? 29:33 · Thank you, Dr. Calabrese 31:01 · Thanks for listening 31:26 We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.
Traumatic brain injuries (TBI) like concussions are not uncommon, especially in children and older adults. These injuries can have both short-term and lasting effects on the brain, but what about their impact on cognitive function? Dr. Deling He of UW–Madison's Cognitive-Communication in Aging and Neurogenic Disorders Laboratory (CCANDL) lab joins the podcast to discuss her research on the connections between TBI, speech pathology and cognition and what her study findings mean for people with a history of TBI. Guest: Deling He, PhD, postdoctoral research associate, Cognitive-Communication in Aging and Neurogenic Disorders Laboratory, Department of Communication Sciences and Disorders, UW–Madison Show Notes Read the study from the University of California, San Francisco (UCSF), “Traumatic Brain Injury Strikes 1 in 8 Older Americans,” mentioned by Dr. Chin at 0:30 on the UCSF website. Learn more about Dr. He's study in the article, “TBI linked to long-term cognitive decline in preclinical Alzheimer's disease,” published on Healio's website. Learn more about the Cognitive-Communication in Aging and Neurogenic Disorders Laboratory (CCANDL) on their lab website. Learn more about Dr. He on the CCANDL website. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. All donations go toward outreach and production.
In the first installment of this 2-part episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the AAO Eyecelerator with guests Julia A. Haller, MD, CEO, and David F. Chang, MD. Welcome to the Eyeluminaries podcast 00:10 Quick recap of episode 34 00:52 Intro of Julia A. Haller, MD, CEO 01:47 Tell us about changes you're seeing in leading a large academic center 02:16 How has residency changed in the last years? 06:23 Why are you involved in the Ophthalmology Foundation? 13:05 Intro of David F. Chang, MD 16:51 What do you think about the future of robotics in cataract surgery? 17:51 How do you continue to involve the patient in their care? 20:15 Dr. Chang discusses premium lenses 22:43 What's going on with EyeSustain and what are you excited about in the future? 27:00 Thank you! 35:30 Julia A. Haller, MD, is ophthalmologist-in-chief and CEO at Wills Eye Hospital. David F. Chang, MD, is a world-renowned cataract surgeon and innovator in the field. He is clinical professor of ophthalmology at the University of California, San Francisco, and is in private practice in Los Altos, Calif. He is also the chair of the EyeSustain advisory board. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.
Active or not active, that is the question. In this week's episode we interview Alexandra Villa-Forte, MD, MPH, a staff physician in the Center for Vasculitis Care and Research at Cleveland Clinic and a leading vasculitis expert, on a pragmatic approach to recognizing disease activity in patients with ANCA vasculitis. · Intro 0:01 · Welcome Alexandra Villa-Forte, MD, MPH 0:10 · Dr. Brown sketches a potential patient that may be seen in practice 0:40 · How are you monitoring patients' kidneys? 1:28 · How reliable are ‘no casts' results in urinalysis tests? 4:15 · What is happening in the glomeruli? 5:23 · The importance of monitoring the urinalysis of patients with ANCA vasculitis 7:06 · Symptoms to watch for when tapering off medications 7:43 · Different scenarios with lung symptoms 9:35 · Evaluating patients with GPA; looking at the nose, ear and sinuses 12:20 · Neurologic symptoms in ANCA vasculitis 14:24 · Laboratory monitoring 15:52 · Should ANCA titers be a part of routine vasculitis monitoring? 17:05 · What is your approach using PJP prophylaxis in ANCA-associated vasculitis? 18:05 Thank you, Dr. Villa-Forte! 20:25 We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. Disclosures: Brown reports no relevant financial disclosures. Healio was unable to confirm relevant financial disclosures for Villa-Forte at the time of publication.
This special edition episode features the latest installment of Healio Community's book club. Physician author Eric Topol, MD, discusses his book, Super Agers: An Evidence-Based Approach to Longevity, a guide to the science of living a long life free of debilitating diseases with Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology. · Intro by Adam J. Brown, MD 0:01 · A warm welcome by Leonard H. Calabrese, DO 0:47 · Introducing Eric Topol, MD 1:12 · “Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again” but did you think it would happen this fast? 1:54 · Let's get into “Super Agers” 3:46 · What's killing most people? 6:33 · An evidence-based treatise on healthy aging 9:42 · The role of immune health in longevity 12:55 · What's next on the horizon? 16:14 · A candle in the dark 19:40 · Minimizing the risk of getting old while you age 22:14 · The influence of health behaviors on immunologic wellness 25:15 · The hot issues: GLP-1's 26:28 · A new world for immunology 31:50 · Thank you, Dr. Topol 33:09 · Thanks for listening 33:57 Don't miss out! To engage in future conversations like this with physician authors on Healio Community, register here. We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. Disclosures: No products or companies that would require financial disclosure are mentioned in this episode.
In this special edition episode, recorded live at the ASCO Annual Meeting, hosts Shikha Jain, MD, and Edward Kim, MD, honor Healio's 2025 Disruptive Innovators for their positive disruption in the field of hematology/oncology, and for pushing the status quo to improve clinical practice. • Welcome to the fourth annual Healio Disruptive Innovator Awards in hematology/oncology. 1:00 • VK Gadi, MD PhD, presents the Health Equity Award. 3:56 • The Health Equity Award winner, Ana Velázquez Mañana, MD, makes a speech. 6:00 • Morgan Collier presents the Woman Disruptor of the Year Award. 7:38 • Betty S. Pace, MD, accepts the Woman Disruptor of the Year Award. 9:19 • The Social Media Influencer Award, presented by Eleonora Teplinsky, MD. 11:53 • Amani Jambhekar, MD, also known as @ajvictorymd on Instagram and TikTok, accepts the Social Media Influencer Award. 13:13 • Brenda M. Nevidjon, MSN, RN, FAAN, presents the Advanced Practice Trailblazer Award. 14:40 • Ashley Leak Bryant, PhD, RN, OCN, FAAN, delivers her acceptance speech for the Advanced Practice Trailblazer Award. 16:19 • Kamal Jethwani, MD, MPH, presents the Patient Voice Award. 18:44 • Founder Kimberly Richardson, MA, accepts the Patient Voice Award for the Black Cancer Collaborative. 20:44 • Healio's chief content officer, Joan-Marie Stiglich, ELS, presents the NextGen Disruptor Award to Nazli Dizman, MD. 22:22 • The Clinical Innovation Award goes to UNC Lineberger Comprehensive Cancer Center for their at-home symptom reporting, led by Ethan Basch, MD, MSc. 24:18 • Hope S. Rugo, MD, wins the Lifetime Disruptor Award. 26:48 • The Industry Breakthrough Award goes to Breyanzi (lisocabtagene maraleucel, or liso-cel) from Bristol Myers Squibb. 30:57 • On behalf of Bristol Myers Squibb, Amy Corrao, MSN, NP-C, accepts the Industry Breakthrough Award. 32:33 • Thanks to all of the winners, nominees and sponsors! 35:39 • Thanks for listening. 36:21 We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Read the full coverage from Healio's Disruptive Innovators here.
In this special crossover podcast episode, Tuesday Night IBS co-hosts Jeffrey Roberts MSEd BSc and Erica Dermer are joined live by Dr. William Chey, Amanda Lynett MS RDN and Kate Scarlata MPH RDN at FOOD The Main Course in Ann Arbor, MI. This episode discusses the following topics:The evolution of FOOD: The Main Course over the years and why dietitians should attendThe role and benefit of incorporating GI dietitians into integrated care modelsThe evolution of GI dietitians at major GI meetings like DDWIBS, your diet and the microbiomeStress, your diet and IBSGLP-1 use and increased GI symptomsCombating GI misinformation onlineOstomies for severe constipation?Check out even more episodes at Healio's Gut Talk Podcast website and submit comments and questions to guttalkpodcast@healio.com. Check out Tuesday Night IBS for more evidence-based webinars and podcasts at TuesdayNightIBS.com.
In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from Octane's Ophthalmology Technology Forum with guests Tibor Juhasz, PhD, Richard L. Lindstrom, MD, Sumit “Sam” Garg, MD and Jean-Pierre Hubschman, MD. Welcome to the Eyeluminaries podcast 00:05 Review of episode 33 00:49 Intro of Tibor Juhasz, PhD 01:35 Tell us about your background and how you changed LASIK, cataract and glaucoma surgery. 02:27 How is ViaLase impacting glaucoma treatment? 06:55 How the treatment works 08:24 The importance of having a good team 11:02 Intro of Richard L. Lindstrom, MD 12:58 What is your perspective on what is happening today and what changes are you hoping for? 14:28 Integrated eye care delivery 17:00 Dentistry, a future model for eye care 17:50 Post-graduate medical education is changing 19:09 Was there a technology that you thought was a slam dunk and failed? 23:01 Any technology that you didn't expect to take off? 24:37 Intro of Sumit “Sam” Garg, MD 26:58 What do you see changing in ophthalmology residency programs around the country? 28:52 How do you instruct young physicians to be collaborative in care? 30:42 If you weren't a cornea specialist (or a model) what would you be? 32:10 Advice for young ophthalmologists today? 33:42 Share a Jim Mazzo story with us! 35:28 Intro of Jean-Pierre Hubschman, MD 37:07 Why did you, with a robotics company, decide to start in cataract surgery? 38:23 How do you become more efficient in robotic surgery? 41:00 How do we work on the economic side of this? 43:38 What's it like running a company vs being a retina surgeon? 44:46 Give us your feedback 48:16 Thanks for listening 48:30 Tibor Juhasz, PhD, is the founder and CEO of ViaLase Inc. He was also the co-founder of IntraLase and LenS. Richard L. Lindstrom, MD, is the founder and an attending surgeon at Minnesota Eye Consultants, an adjunct professor emeritus at the University of Minnesota, department of ophthalmology as well as the global chief medical editor of Ocular Surgery News. Sumit “Sam” Garg, MD, is the medical director at the Gavin Herbert Eye Institute at UC Irvine. Jean-Pierre Hubschman, MD, is the co-founder and CEO of Horizon Surgical Systems. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm disclosures for Garg, Hubschman, Juhasz, and Lindstrom at the time of publication.
In this episode John A. Hovanesian, MD, FACS, and Jim Mazzo are live from SightLine at the ASCRS meeting with guests Nicole R. Fram, MD, Kerry D. Solomon, MD, Vance Thompson, MD, and Steve Speares. Welcome to the Eyeluminaries podcast 00:02 Review of episode 32 00:55 Intro of Nicole Fram, MD 01:16 Tell us why the MAHRVELS team is likely to be the leading fundraisers and why you picked your character for the team to portray (The Scarlet Witch)? 02:24 Meeting about complications from cataract surgery, what do you think is the next big phase on how we're going to handle complications with technology? 04:05 Psychology of managing patients/conveying care 05:42 What advice do you give to people who are starting their career? 06:50 Intro of Kerry Solomon, MD 09:30 What do we often get wrong with cataract surgery and what do we often get right? 10:25 How do you stay an entrepreneur and a leading physician? 11:55 What is Operation Sight? How did you create it? 14:19 Where will keratorefractive surgery and lens-based surgery be in 5 or 10 years? 18:30 Intro of Vance Thompson, MD 21:24 What's it like to be ASCRS president? 21:59 What is BRiCS and why is it important? 23:54 You've created a culture; can you talk about that culture you've created at your institute? 29:30 Tell us about your winery! 33:28 Intro of Steve Speares 36:45 ASCRS just wrapped up. Your idea of creating a SightLine with a business approach, what did you do and what was the idea? 38:00 As you look back and you look ahead, what changes do you hope to make? What do you hope your legacy will be at ACSRS? 40:57 Can you expand more on how Washington, DC and Trump administration will impact your society/group? 44:19 Richard Lindstrom in ASCRS hall of fame, tell us your own perspective and a good story 46:29 Preview of episode 34 52:09 Give us your feedback 52:40 Thanks for listening 52:56 Nicole Fram, MD, is an adjunct assistant professor at the John A. Moran Eye Institute at the University of Utah. She is also the secretary for ASCRS, is a member of the Cataract Clinical Committee, and leads the Ophthalmology Quicksand Chronicles podcast with co-host Elizabeth Yeu, MD. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Kerry Solomon, MD, is internationally renowned for LASIK and refractive cataract surgery. He is the co-founder of Operation Sight. He is the former chairman of the ASCRS FDA Committee. Steve Speares, MD, is the executive director at ASCRS. Vance Thompson, MD, is the founder of Vance Thompson Vision and director of refractive surgery in Sioux Falls, SD. He serves as a professor of ophthalmology at the Sanford School of Medicine at the University of South Dakota. Thompson is the immediate past president of ASCRS. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Fram, Speares, Solomon, and Thompson at the time of publication.
In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news from Washington with guest Mark Leahey. Welcome to the Eyeluminaries podcast :02 Review of episode 31 :40 BVI Medical names a new CCO 2:20 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions 5:42 Tenpoint submits new drug application for presbyopia combination therapy 7:33 Alcon acquires majority stake in Aurion Biotech 10:29 FDA approves Encelto for macular telangiectasia type 2 14:50 Intro of Mark Leahey 17:28 There is a lot of attention on the HHS restructuring. What are your insights into what has happened to date, and what could happen in the future? 20:10 What do you think about the leadership? 23:44 Let's talk about sustainability. Tell us about the medical device industry's collective interest and challenges in regard to moving toward environmentally sustainable initiatives. 24:59 Let's talk about leadership: Dr. Marty Makary and Dr. Oz. 27:53 Tariffs are an evolving subject. What is the impact on the medical community? What is your impression on how these will affect us in the short term and long term? 33:20 Preview of episode 33 39:27 Give us your feedback 40:23 Team Mah-rvel: the Party for a Purpose 40:41 Thanks 40:58 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Mark Leahey is the president and CEO for the Medical Device Manufacturers Association (MDMA). Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Leahey.
Send us a textAbout Dr. Jade CoatsDr. Jade Coats is a 2016 of the Southern College of Optometry in Memphis, TN, and since graduation has worked in an OD/MD cataract/refractive surgery practice (McDonald Eye Associates, Rogers, Arkansas) in which she dedicates the majority of her clinical practice to ocular disease, comprehensive eye care, and contact lenses. Honored as a Contact Lens Institute Visionary in both 2023 and 2024, Dr. Coats is also a board member for Women in Optometry, the Intrepid Eye Society, and YoungODsConnect. She is an active member of the American Optometric Association as a graduate of the AOA Leadership Institute 1.0 and 2.0 programs, and was also elected in 2024 to serve as a Director on the Arkansas Optometric Association board. In addition to her clinical work, Dr. Coats serves on the advisory board and/or as a speaker for over ten pharmaceutical companies and is an editorial board member for numerous publications. She also regularly contributes to leading industry publications, with her work appearing in Advanced Ocular Care, Primary Care Ocular News, Healio, Review of Optometry, Optometry Times, Optometric Management, and Modern Optometry, to name a few. Receiving several local, state, and national awards for her dedication to philanthropy and her profession, Dr. Coats has also recently been honored as one of NWA Celebrate Arkansas Magazine's 'Ones to Watch' in 2023. https://digitaleditions.walsworth.com/publication/?m=9337&i=805683&p=80&ver=html5. In Dr. Coats' spare time, she serves on the Board of Directors for Hope Cancer Resources and Circle of Life Hospice in Northwest Arkansas and has established a non-profit organization known as “Caton's Cubs” that works in coordination with Arkansas Hospice. You may find Dr. Coats enjoys calling the Hogs at Razorback games, scuba diving, traveling the world, or volunteering in her community. (Or, hanging out with her husband, Jeff Coats, who is also an Optometrist!)
Send us a textAbout Dr. Jade CoatsDr. Jade Coats is a 2016 of the Southern College of Optometry in Memphis, TN, and since graduation has worked in an OD/MD cataract/refractive surgery practice (McDonald Eye Associates, Rogers, Arkansas) in which she dedicates the majority of her clinical practice to ocular disease, comprehensive eye care, and contact lenses. Honored as a Contact Lens Institute Visionary in both 2023 and 2024, Dr. Coats is also a board member for Women in Optometry, the Intrepid Eye Society, and YoungODsConnect. She is an active member of the American Optometric Association as a graduate of the AOA Leadership Institute 1.0 and 2.0 programs, and was also elected in 2024 to serve as a Director on the Arkansas Optometric Association board. In addition to her clinical work, Dr. Coats serves on the advisory board and/or as a speaker for over ten pharmaceutical companies and is an editorial board member for numerous publications. She also regularly contributes to leading industry publications, with her work appearing in Advanced Ocular Care, Primary Care Ocular News, Healio, Review of Optometry, Optometry Times, Optometric Management, and Modern Optometry, to name a few. Receiving several local, state, and national awards for her dedication to philanthropy and her profession, Dr. Coats has also recently been honored as one of NWA Celebrate Arkansas Magazine's 'Ones to Watch' in 2023. https://digitaleditions.walsworth.com/publication/?m=9337&i=805683&p=80&ver=html5. In Dr. Coats' spare time, she serves on the Board of Directors for Hope Cancer Resources and Circle of Life Hospice in Northwest Arkansas and has established a non-profit organization known as “Caton's Cubs” that works in coordination with Arkansas Hospice. You may find Dr. Coats enjoys calling the Hogs at Razorback games, scuba diving, traveling the world, or volunteering in her community. (Or, hanging out with her husband, Jeff Coats, who is also an Optometrist!)
In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Hawaiian Eye meeting with guests Paul Singh, MD, Candy Simerson, Jeffrey Goldberg, MD, PhD, and Roger Goldberg, MD, MBA. Welcome to the Eyeluminaries podcast :02 Review of episode 30 3:23 Intro of Paul Singh, MD 3:40 What are the future trends in glaucoma you're most excited about? 5:10 What challenges do you see in running your practice that didn't exist in your dad's day? 8:36 You've got a great medical office, a very busy consulting and research practice, you play in a band and you have a young family. What advice would you give others in keeping it all in balance? 12:09 Besides your dad and the two of us, who do you look up to in eye care? 14:45 Singh sings a Funkadesi song 18:16 Intro of Candy Simerson 20:36 When you come into a new practice to consult, what are the most common areas you see where improvement can be made? 21:41 What about the finances? What areas in finances do you see where improvement can be made? 24:27 In your many years in ophthalmology, what are the biggest challenges you've experienced? 26:10 What type of practice should consider a sale to private equity? What type of practice should not? 29:34 What advice would you give a company representative who wants to win business from a big ophthalmology practice? 32:29 Intro of the Goldbergs 36:25 Jeff Goldberg, MD, PhD 36:50 Roger Goldberg, MD, MBA 37:21 Jeff, why glaucoma instead of retina? 38:43 Roger, why retina instead of glaucoma? 39:37 Mazzo discusses neuroprotection in retina and glaucoma. 41:14 What is entrepreneurship like today? What's your advice? What is challenging and what is positive? 43:10 Mazzo discusses being realistic about innovations. 48:30 What is private practice like today? 49:31 How do cornea specialists better understand glaucoma specialists? 53:05 How do cornea specialists better understand retina specialists? 54:13 Tell us about emmecell. 55:50 Preview of episode 32 59:19 Give us your feedback 1:00:18 Thanks 1:00:30 Jeffrey Goldberg, MD, PhD, is professor and chair of ophthalmology at the Byers Eye Institute at Stanford University and a member of the National Academy of Medicine. Roger Goldberg, MD, MBA, board certified by the American Board of Ophthalmology and is an active member of the American Society of Retinal Specialists, the Retina Society and the American Academy of Ophthalmology. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Candy Simerson is the senior vice president of practice operations at Vision Integrated Partners. I. Paul Singh, MD, is the president of The Eye Centers of Racine & Kenosha, Ltd., founded in 1981 by his father, Dr. Kanwar A. Singh. He is a founding member of the band, Funkadesi, a mix of Indo-Afro-Caribbean style music. The band tours the world spreading the message “one family, many children.” We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for the Goldbergs, Simerson and Singh at the time of publication.
In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Steven Dell, MD, about his career and the creation of markets in the field of ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 29 1:28 Bausch + Lomb acquires Elios Vision 2:07 ImprimisRx awarded $34.9 million in trademark infringement suit against OSRX 5:00 Study of atropine-based myopia treatment fails to meet primary efficacy endpoint 7:31 Intro of Steven Dell, MD 11:20 You have created markets with new technologies and companies. Can that continue in today's market? 13:28 Dell discusses presbyopia market development. 14:11 You created a questionnaire that you used in your practice, which has become known as the Dell Questionnaire. What do we need to do better in treating our cataract patients? 16:20 What technologies are going to be the most important in the future? 20:24 What has changed in your office environment, i.e., the role of ODs, admin, staff? 22:00 Dell discusses Lindstrom's Integrated Eye Care Delivery Model. 23:08 What advice would you give a younger Steven Dell? 27:16 Neurotech Pharmaceuticals announced that chief commercial officer Scott Hunter died on Dec. 3. 33:06 Give us your feedback 34:43 Thanks 34:51 Steven J. Dell, MD, is a board-certified ophthalmologist in Austin and the Medical Director of Dell Laser Consultants. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Dell at the time of publication.
In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the ASH Annual Meeting and Exhibition, as well as Healio's top headlines from the meeting. Gwen L. Nichols, MD, reviews a panel discussion on how hematologists and oncologists can best address patients' concerns as AI's role in medicine invariably expands. :24 Thomas G. Knight, MD, addresses financial toxicity for people with blood cancer. 6:29 Charles S. Abrams, MD, discusses results of the HIBISCUS trial and its implications for vaso-occlusive events. 16:30 Read the full coverage here: AI in hematology: ‘The good, the bad and the ugly' Mitigating financial toxicity 'better than any drug' for people with cancer Etavopivat could offer ‘great benefit' in sickle cell disease ASH recognizes Judith Kleinerman, MD, with Exemplary Service Award GLP-1s reduce thrombosis risk among people with diabetes, regardless of obesity We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Disclosures: Jain reports no financial disclosures. Abrams reports he is chair of the ASH Research Collaborative's Sickle Cell Disease Clinical Trials Network Oversight Committee. Knight reports no relevant financial disclosures. Nichols reports no relevant financial disclosures.
In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the 2024 World Conference on Lung Cancer, as well as Healio's top headlines from the meeting. With insights from Benjamin P. Levy, MD, and top headlines from the conference, Meeting Mic is your on-the-go source for highlights, pearls, and perspectives across all specialties. Benjamin P. Levy, MD, discusses key takeaways from the meeting. 0:49 Read the full coverage here: Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard' Source: Zhou C, et al. Abstract 2700. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. Perioperative nivolumab improves outcomes in resectable NSCLC Source: Forde PM, et al. Abstract 3589. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. Despite progress, barriers to lung cancer biomarker testing persist Source: Smeltzer M, et al. Abstract 3000. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Disclosures: Jain reports no relevant financial disclosures. Healio could not confirm relevant financial disclosures for Levy at the time of posting.
In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Tom Mitro about his career and impact in ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 26 :58 FDA grants fast track designation to brepocitinib for noninfectious uveitis 1:42 I. Howard Fine, MD, esteemed ophthalmologist, dies 3:54 First subjects dosed in phase 3 trial of phentolamine ophthalmic solution for presbyopia 5:48 LENZ Therapeutics submits NDA for drops to treat presbyopia 7:57 Intro of Tom Mitro 10:40 Tell us about your journey in ophthalmology 12:38 Tell us about the new dry eye drug from Signal 12. 15:53 How much sensation is on the forehead if the drug is well tolerated? 24:13 What are your thoughts on the current ophthalmology market? 26:01 Tell us a funny story about Jim Mazzo and about John Hovanesian. 28:51 Preview of episode 29 33:25 Give us your feedback 34:34 Thanks 34:50 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Tom Mitro is the president and chief operating officer for Aerie Pharmaceuticals. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Mitro at the time of publication.
On this special edition episode, Shikha Jain, MD, with Physicianary's Hansa Bhargava, MD, and Mend the Gap's Dagny Zhu, MD, discuss the evolution of empowering yourself and others and advocacy with a panel of guests. • Intro 1:01 • What does it mean to empower women in medicine, and what are the ways that we can really empower others to achieve the things that they may not see for themselves? 2:39 • What are some ways in which you have empowered or hope to empower women in medicine? Are there tips or skills that have worked well? 5:43 • How have you been empowered by others, or have helped others find their voices? 8:38 • Do you agree that the conversation is changing toward a cultural shift in empowerment for women in health care? 13:53 • What are some challenges facing advocacy and empowerment? What do you do when your advocacy work is not being received or it is a struggle to speak up for someone? 18:40 • Emphasizing the importance of communication in advocacy work. 24:00 • Intro to Physicianary's part 3 on physician burnout and work-life balance. 24:16 • Thanks for listening 25:00 Vineet Arora, MD, MAPP (NAM), is a Herbert T. Abelson professor of medicine, vice dean of education in the biological sciences division and dean for medical education at the University of Chicago Pritzker School of Medicine. She is also an elected member of the National Academy of Medicine. She is a founding member of the 501c3 Women of Impact and advisor to the Women in Medicine Summit. Jennifer Bepple, MD, MMCi, is a double board-certified physician in urology and informatics. She is a member of the American Telemedicine Association, American Urologic Association and American Medical Informatics Association and holds a certification from the American Board of Telehealth and the American Board of AI in Medicine. Hansa Bhargava, MD, is Healio's chief clinical strategy and innovation officer. Listen to her Healio podcast, Physicianary. Shikha Jain, MD, FACP, is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the division of hematology and oncology, the director of communication strategies in medicine and the associate director of oncology communication & digital innovation at the University of Illinois Cancer Center in Chicago. Mara Schenker, MD, FACS, FAOA, is an orthopedic trauma surgeon at Grady Memorial Hospital. She is double board certified in orthopedic surgery and clinical informatics. She serves as the chief of orthopedics and associate chief medical information officer. She is an associate professor of orthopedics at Emory University School of Medicine. She serves on multiple boards for medical and digital technology advisory and sits on major national committees for the American Academy of Orthopaedic Surgeons, AAMC, American College of Surgeons and the Orthopaedic Trauma Association. Dagny Zhu, MD, is a cornea, cataract and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. She can be reached on X @DZEyeMD. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Disclosures: The hosts and guest report no relevant financial disclosures.
On this special edition episode, Dagny Zhu, MD, with Oncology Overdrive's Shikha Jain, MD, and Physicianary's Hansa Bhargava, MD, discuss leadership in medicine and the importance of mentorship with a panel of guests. Intro 0:28 Meet the panel 2:00 Vineet Arora, MD 2:12 Jennifer Bepple, MD 2:29 Mara Schenker, MD, FACS 2:55 In this episode 3:21 How did you become the leader that you are today? And what is your advice for young physicians who want to find themselves in your position one day? 3:27 Were you always “leadership material” or was it something you developed over time? 10:26 How has mentorship improved your outlook on your career? And what is your advice on finding a good mentor? 12:33 What are some quick, easy tips to finding a mentor? 23:07 Thanks 25:38 Join us for part two on Oncology Overdrive 25:41 Vineet Arora, MD, MAPP (NAM), is a Herbert T. Abelson professor of medicine, vice dean of education in the biological sciences division and dean for medical education at the University of Chicago Pritzker School of Medicine. She is also an elected member of the National Academy of Medicine. She is a founding member of the 501c3 Women of Impact and advisor to the Women in Medicine Summit. Jennifer Bepple, MD, MMCi, is a double board-certified physician in urology and informatics. She is a member of the American Telemedicine Association, American Urologic Association and American Medical Informatics Association and holds a certification from the American Board of Telehealth and the American Board of AI in Medicine. Hansa Bhargava, MD, is Healio's chief clinical strategy and innovation officer. Listen to her Healio podcast, Physicianary. Shikha Jain, MD, FACP, is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the division of hematology and oncology, the director of communication strategies in medicine and the associate director of oncology communication & digital innovation at the University of Illinois Cancer Center in Chicago. Listen to her Healio podcast, Oncology Overdrive. Mara Schenker, MD, FACS, FAOA, is an orthopedic trauma surgeon at Grady Memorial Hospital. She is double board certified in orthopedic surgery and clinical informatics. She serves as the chief of orthopedics and associate chief medical information officer. She is an associate professor of orthopedics at Emory University School of Medicine. She serves on multiple boards for medical and digital technology advisory and sits on major national committees for the American Academy of Orthopaedic Surgeons, AAMC, American College of Surgeons and the Orthopaedic Trauma Association. Dagny Zhu, MD, is a cornea, cataract and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. She can be reached on X (formerly Twitter) @DZEyeMD. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Disclosures: The hosts and guest report no relevant financial disclosures.
Dr. Greg talks with Emily L. Weis, MD, MS, with the University of Rochester, who recently was featured in an article in Healio about how physicians are dealing with a rise in difficult patient encounters and what may be behind the uptick.
This week we had such an interesting conversation with Dr. Erica Barnell. Dr. Barnell is the Co-Founder and Chief Medical and Science officer for Geneoscopy, Inc! Geneoscopy is a life-sciences start-up company that leverages eukaryotic biomarkers to non-invasively diagnose, monitor, and treat gastrointestinal disease. The idea for Geneoscopy was conceived during Dr. Barnell's first clinical rotation while earning her MD/Ph.D. at Washington University School of Medicine in St. Louis. Specifically, Erica encountered a woman with Stage IV colorectal cancer (CRC) who had never undergone a colonoscopy, citing the inconvenience and burden of attending a traditional colonoscopy as key barriers. Dr. Barnell developed an easy non-invasive stool test to screen for colon cancer and she is now expanding it to the IBD space. She and her team are working to be able to use this RNA screening tool to allow for better prediction of treatment outcomes, disease monitoring and more. We talked to her about developing her initial test, going through the FDA approval process, and then developing a company while still finishing her MD/PhD. We also talked to her about starting a company with her brother and all of the many life changes she went through during it's initial stage as well. We discussed RNA technology and she gave us a quick lesson on it, and finally we discussed her participation in the Crohn's & Colitis Foundation's IBD Innovate Conference earlier this year and how it helped her premier her product to the IBD space and to explore possible partnerships and funding opportunities. Robin and I are big geeks for research and innovation and this conversation with Erica was so fun. Please keep in mind that the views and opinions expressed in this program are those of the speakers and should not be considered medical or legal advice. Please consult with your healthcare team on any changes to your disease, diet, or treatment. We want you to stay safe and healthy! ;)Links: Article about the IBD Innovate Conference- Crohn's & Colitis Foundation- USAEpisode of Oncology Overdrive from Healio with Dr. BarnellFDA Approves ColoSense test- Colorectal Cancer AllianceTune in to the Patient Advocacy Voices Podcast todayJoin Sanofi's Eric Racine to meet the unsung heroes leading patient advocacy organizationsListen on: Apple Podcasts SpotifyLet's get social!!Follow us on Instagram!Follow us on Facebook!Follow us on Twitter!
In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 ASCO Annual Meeting, as well as Healio's top headlines from the meeting. Joseph A. Greer, PhD, discusses how early palliative care via telehealth had an equivalent impact on quality of life as in-person visits for patients with advanced non-small cell lung cancer. :27 Charu Aggarwal, MD, MPH, FASCO, further discusses these findings during a press briefing. 3:30 Heinz-Josef Lenz, MD, shares his thoughts on the first-line immunotherapy combination of nivolumab and ipilimumab in colorectal cancer. 4:35 Fumiko Chino, MD, discusses findings on the need for a more effective and transparent prior authorization process to ensure patients receive timely access to essential pain management. 7:09 Suneel Kamath, MD, provides an overview of findings assessing how the microbiome profile of early-onset pancreatic adenocarcinoma is distinct from that of average-onset disease. 10:22 Julie R. Gralow, MD, FACP, FASCO, discusses the important implications of a prospective study on young breast cancer survivors who attempted pregnancy and became pregnant. 12:54 Read the full coverage here: https://www.healio.com/news/hematology-oncology/20240602/we-have-the-technology-telehealth-increases-access-to-palliative-care-for-cancer https://www.healio.com/news/hematology-oncology/20240602/practicechanging-data-support-firstline-immunotherapy-combination-in-colorectal-cancer https://www.healio.com/news/hematology-oncology/20240531/findings-highlight-need-to-improve-prior-authorization-process-for-cancer-pain-management https://www.healio.com/news/hematology-oncology/20240603/tumor-microbiome-profiles-in-pancreatic-cancer-differ-by-age-of-onset https://www.healio.com/news/hematology-oncology/20220611/intramuscular-recombinant-erwinia-asparaginase-active-safe-in-leukemia-lymphoma-subsets Glucose-lowering drugs reduce risk for obesity-related cancers Source: Lin CH, et al. Abstract 10508. Presented at: ASCO Annual Meeting; May 30 – June 4, 2024; Chicago. Chemotherapy regimen improves survival in advanced esophageal cancer Source: Hoeppner J, et al. Abstract LBA1. Presented at: ASCO Annual Meeting; May 31-June 4, 2024: Chicago. Disclosures: Chino reports no relevant financial disclosures. Greer reports a consulting role with BeiGene; research funding from Blue Note Therapeutics and NCCN/AstraZeneca; and royalties from Oxford University Press and Springer Publishing Company. Please see the abstract for all other researchers' relevant financial disclosures.[JJ1] Kamath reports no relevant financial disclosures. Lenz reports honoraria from, consulting/advisory roles with, or travel, accommodations or expenses from 3T Biosciences, Bayer, Bristol Myers Squibb, Boehringer Ingelheim, Fulgent Genetics, G1 Therapeutics, GSK, Isofol Medical, Jazz Pharmaceuticals, Merck Serono, Oncocyte and Roche. Please see the abstract for all other researchers' relevant financial disclosures.
See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog There is a lot of New Medical Information that is important for patients to make healthy decisions about their care or the care of their loved ones that you won't hear about on the news. For new research to reach you, the public, a researcher or a drug company has to spend a great deal of money for the public relations people to push information into the light. I compiled the research I thought you might want to know about that has been discovered during the past 6 months. I always use these studies to educate my patients and to change my protocols for treatment, although many of them have been part of my practice for quite a while, because they just confirm what I have been seeing in my Integrative and preventive medical practice for years. The First Group of Discoveries Relate to Menopause, and the Risks of Being Menopausal The most recent article in Lancet confirmed what has been obvious to me in my GYN practice for years. I am not sure why this actually required a study to prove that Menopause is tied to a higher rate of depression and anxiety, in conjunction with insomnia, higher stress perception, and hot flashes. This study documented what the loss of estradiol, progesterone and testosterone can do to women in menopause. The sad fact is that this article doesn't tell the reader what they need to know, how to treat these symptoms. However, I will let you in on a self-discovered fact: The replacement of the hormones that disappear before and during menopause can be replaced in a non-oral delivery system to treat these symptoms. I have 40 years of medical practice that proves my findings that agree with the problem, and my treatment with hormones. The Lancet: Menopause tied to mental health issues in certain women A study found that when certain women are menopausal, they increase their risk of Depression, anxiety, bipolar disorder who experienced stressful life events, had poor sleep related to hot flashes, or had previous depressive symptoms of depression were more likely to develop menopause-related mental health problems. Researchers wrote in the journal The Lancet that some women escape the mental health effects of menopause altogether. HealthDay News (3/6) Another recent study about menopause discovers that a lack of estradiol in the post menopause causes women to have trouble thinking. I agree with that revelation, but why doesn't the research take the next step and suggest a treatment to prevent this result of hormone loss? Why doesn't the research tell us how to help women think by replacing their estradiol? Many other studies confirm that replacing estradiol will delay the onset of dementia by 10 years. Another study reveals that the replacement of testosterone will delay dementia it 10 more years. These studies occurred over 20 years ago, but this study doesn't cite them. Poor and worsening cognitive function is one of the most frequent complaints of my new patients coming to BioBalance Health® for treatment of menopause and low testosterone with bioidentical hormone pellets. Dr Maupin: I am continually reminded of the importance of testosterone and estradiol replacement is to aging men and women when they come back for their second pellet insertion and review their list of the symptoms they complained of before they started E and T pellets The most frequent response I witness when I ask if a woman's ability to think, do her job and stay organized is completely better after 3 months of Estradiol and Testosterone pellets, is crying with relief! Many patients are deeply worried that they are developing dementia, specifically Alzheimer's Disease when they first come to me, but are able to go back to work and or experience a renewed quality of life because their ability to think, they can now feel confident in their professions and careers. Dr M Estradiol associations with brain functional connectivity in postmenopausal women Testo, Abigail A. BS1; Makarewicz, Jenna BS1; McGee, Elizabeth MD2; Dumas, Julie A. PhD1 Author Information From the 1Department of Psychiatry 2Department of Obstetrics, Gynecology, and Reproductive Sciences, Larner College of Medicine, University of Vermont, Burlington, VT. The results illustrate the relationship between estradiol level and functional connectivity in postmenopausal women. They have implications for understanding how the functioning of the brain changes for individuals after menopause that may eventually lead to changes in cognition and behavior in older ages. © 2024 by The Menopause Society I have another problem with studies that should be shared with patients is that they often imply that menopausal women are “crazy” instead of saying that women after menopause develop mental health issues that can be treated with hormone replacement. Women who are menopausal are not mentally ill they are hormone deprived! I view this as a “slam” and divisive attack on aging women. The fact that if we gave women what they need …hormonal replacement ….they would not suffer the symptoms of mental health disorders. Menopause tied to mental health issues in some women A study found that women who experienced stressful life events, who had poor sleep due to nighttime hot flashes, or who had previous depressive symptoms or depression were more likely to have menopause-related mental health problems. Researchers wrote in the journal The Lancet that some women escape the mental health effects of menopause altogether. Full Story: HealthDay News (3/6) The Second Group of Articles Is About The Loss Of Estrogen In Menopause Causes Heart Failure and Atrial Fibrillation. This article from the European Society of Cardiology reveals that the longer women live without estrogen (e.g. is menopausal), the higher risk of developing heart failure and atrial fibrillation. Once again, there is no mention about how to prevent this disease! Why can't they study the women who replaced their hormones and compare them to the women who didn't? Hormone Therapy May Boost Weight Loss for Postmenopausal Women Who are Overweight or Obese On Semaglutide, Study Finds My practice BioBalance Health® has a weight loss program that is very effective for weight loss using Semaglutides, and terzipatide. For women who are menopausal we have found that they lose weight much more quickly if they are on E2 and T pellet hormone replacement. This research article confirms the findings of this study. If you are menopausal and have gained weight after menopause that is hormonal and the faster, you can get on non-oral estradiol and testosterone replacement then you will be more likely to get to your ideal weight! March 18, 2024 Hormone therapy may boost weight loss for postmenopausal women on Semaglutides. Healio (3/18, Welsh) reports, “Hormone therapy was associated with an improved weight-loss response for postmenopausal women with overweight or obesity treated with Semaglutides, according to cohort study results published in Menopause.” In the study, “postmenopausal women on hormone therapy had a higher percentage of total body weight loss at 3 (7% vs. 5%; P = .01), 6 (13% vs. 9%; P = .01), 9 (15% vs. 10%; P = .02) and 12 (16% vs. 12%; P = .04) months of semaglutide treatment compared with no hormone therapy.” How and Why to Treat Metabolic Syndrome Metabolic Syndrome is a combination of hypertension, high lipids, insulin resistance, obesity, prediabetes or diabetes, large abdominal measurement. This combination puts patients at risk for heart disease and early death. Many conditions and outcomes have been associated with metabolic syndrome, but now we have a treatment that can prevent one of the outcomes of this syndrome, the generic drug Metformin ER. Metformin, Cognitive Function, and Changes in the Gut Microbiome Endocrine Reviews, Volume 45, Issue 2, April 2024, Pages 210–226, Published: 21 August 2023 Article history Abstract The decline in cognitive function and the prevalence of neurodegenerative disorders are among the most serious threats to health in old age. Metformin can preserve cognitive function by treating metabolic syndrome and improving the gut biome that produces neurotransmitters. I am not naive enough to believe that the only thing that your brain needs to perform well is two sex hormones (E2 and T). This new research from the Endocrine Society describes how the generic, inexpensive medication Metformin ER, can help preserve an aging patient's ability to think. That is primarily because the brain has insulin receptors, and when a patient has insulin resistance brain cells don't receive enough blood-sugar to be able to think! By taking metformin ER (extended release) plus replacing estradiol plus testosterone in pellet form, the brain gets what it needs (blood sugar) and patients can think again! The second factor the researchers found to be important to brain health and problem solving, is healthy gut bacteria in the intestines. This requires eating whole foods, especially fruits and vegetables every day, and not eating fast food, alcohol, simple sugars, and preservatives that kill good bacteria. We recommend a daily probiotic by Mega + the lifestyle changes above. If you want to keep your ability to think for your whole life then you need E2 and T in pellet form if you are a woman and T if you are an aging male, plus Metformin ER daily and the above lifestyle changes. Metabolic Syndrome, Obesity, is the Biggest Risk for Cancer Metabolic syndrome may increase cancer risk by 30% People with metabolic syndrome had a 30% higher chance of developing cancer over the course of a decade after diagnosis, according to a study published in the journal Cancer. The researchers also studied inflammation by tracking C-reactive protein, concluding that elevated levels of the protein along with metabolic syndrome were “significantly associated with subsequent breast, endometrial, colorectal and liver cancers.” Full Story: National Public Radio (3/11) The struggle to stay young and healthy is a difficult fight but the most important battle that you will wage as an adult. If people knew the whole truth, would they stop overeating, drinking, smoking, avoiding exercise, or stop taking illicit drugs? I can only hope that if we convince people to take care of themselves better and replace the hormones that are missing as soon as they are clinically deficient, then they will also listen to the truth about the various ways to support their health and prevent disease. I also hope that the doctors who write articles and do research stop treating women like crazy people instead of the gender that actually runs the world and not only nurtures the children but also organizes homes and businesses. We are NOT crazy when we need hormones to be replaced (PMS, MENOPAUSE), we are experiencing symptoms of hormone-deprivation, and we just need to be treated with the hormones that are missing!
In this episode, host Shikha Jain, MD, speaks with Jan Kitajewski, PhD, about blending community need with scientific advancement, his role as the director of a cancer care center and more. • Welcome to another exciting episode of Oncology Overdrive :58 • About Kitajewski 1:08 • The interview 2:59 • Tell me about how you started and your pathway to this position. 3:26 • You have a very diverse background in various fields of medicine. Was there something that drew you to lead a cancer center? 6:15 • What are your thoughts on how institutions can shift their mindsets toward setting up research that is more inclusive of patient diversity in clinical trials? 9:44 • Jain and Kitajewski on The Immortal Life of Henrietta Lacks, mistrust in the health care system, and how institutions can empower their communities. 14:00 • What does a cancer center director do, and what are some things that people may be surprised to know about your position? 16:30 • Jain and Kitajewski on the University of Illinois Cancer Center applying for NCI designation, and what the process entails. 22:05 • Jain and Kitajewski on the challenges and successes that come with physician leadership when making changes at an institution. 29:28 • What is your vision for the future of the University of Illinois Cancer Center? 34:16 • If someone could only listen to the last minute of this episode, what would you want them to take away? 40:13 • How to contact Kitajewski 40:55 • Thanks for listening 41:35 Jan Kitajewski, PhD, is director of the University of Illinois Cancer Center and a professor and head of the department of physiology and biophysics. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Kitajewski can be reached via email kitaj@uic.edu. Disclosures: Jain reports no relevant financial disclosures. Healio could not confirm relevant financial disclosures for Kitajewski at the time of posting.
In the classic holiday film "It's a Wonderful Life", Clarence the angel says "remember, George, no man is a failure who has friends". In the holiday spirit, Your Doctor Friends took Clarence's words to heart, and present to you today the research behind how friendship keeps us healthy. In today's episode, we highlight the growing amount of evidence that supports friendships as a key aspect of our health, and, conversely, how social and emotional isolation often leads to poor health outcomes. The American Psychological Association summarizes, “given the clear benefits of friendship, psychologists say we should promote platonic social connection across society—including in school, at work, in public spaces (such as on public transportation), and through entertainment.” So let's do that today, shall we? And after listening to the episode, maybe reach out to a friend with a quick text, a silly photo, or an invite to meet up for a treat together. It might just help you live longer ;) And bonus dessert topic at the end, we talk about SOME GOOD NEWS in cancer treatment and survivorship! Happy holidays from Your Doctor Friends! We hope you're safe, happy, and healthy :) Resources for today's episode include: An American Psychological Association article titled "The science of why friendships keep us healthy". A Washington Post article titled "Friends can improve your health and well-being especially during the holidays". A systematic review/meta-analysis in PLoS One from 2023 titled "Social isolation as a risk factor for all-cause mortality" A Healio article titled "Cancer death rate drops by 33%, AACR report shows" The AACR press release for the Cancer Progress Report. The full AACR Cancer Progress Report 2023. For more episodes, limited edition merch, or to become a Friend of Your Doctor Friends (and more), follow this link! This includes the famous "Advice from the last generation of doctors that inhaled lead" shirt :) Also, CHECK OUT AMAZING HEALTH PODCASTS on The Health Podcast Network Find us at: Website: yourdoctorfriendspodcast.com Email: yourdoctorfriendspodcast@gmail.com Connect with us: @your_doctor_friends (IG) Send/DM us a voice memo/question and we might play it on the show! @yourdoctorfriendspodcast1013 (YouTube) @JeremyAllandMD (IG, FB, Twitter) @JuliaBrueneMD (IG) @HealthPodNet (IG)
In this episode of Meeting Mic, we bring you Healio's top headlines from ACR Convergence 2023. Eric Roberts, PhD, MPH, compares the uptake of biosimilar infliximab among patients with Medicare, Medicaid and private insurance in the U.S. :19 Shivani Garg, MD, MS, discusses how a therapeutic range of hydroxychloroquine blood levels may reduce the odds of high lupus disease activity. 2:09 Kaleb Michaud, PhD, discusses patients with rheumatoid arthritis who reported having long COVID in the past year demonstrating “many symptoms” of long COVID prior to initial infection. 12:00 Leonard H. Calabrese, DO, highlights the “year in review”, issues in vasculitis, and cautionary notes on CAR T cell therapies. 14:18 Jill Buyon, MD, discusses how pregnant patients with very low anti-Ro antibody titers of less than 1,000 units per mL have minimal-to-no risk for fetal atrioventricular block. 15:15 Read the full coverage here: https://www.healio.com/news/rheumatology/20231113/medicare-fails-to-keep-up-with-medicaid-private-market-on-infliximab-biosimilar-uptake https://www.healio.com/news/rheumatology/20231120/stay-within-hydroxychloroquine-therapeutic-threshold-to-reduce-active-lupus-flare-risk https://www.healio.com/news/rheumatology/20231116/patients-with-rheumatoid-arthritis-report-many-symptoms-of-long-covid-prior-to-infection @LCalabreseDO https://www.healio.com/news/rheumatology/20231113/pregnant-patients-with-low-antiro-titers-have-little-to-no-risk-for-fetal-heart-block Disclosures: Roberts, Garg, Michaud and Calabrese report no relevant financial disclosures. Buyon reports financial disclosures with Bristol-Myers Squibb, GlaxoSmithKline and Related Sciences.
In this episode of Meeting Mic, we bring you Healio's top headlines from ACG 2023. Paul Feuerstadt, MD, FACG, AGAF, discusses data that link health-related quality of life and microbiome composition among patients with recurrent Clostridioides difficile infection. :38 Edward V. Loftus Jr., MD, FACG, discusses results from the INSPIRE trial for ulcerative colitis. 7:52 Jan Wehkamp, MD, PhD, discusses results from the QUASAR study, in which Tremfya outperformed placebo in clinical response patients with ulcerative colitis. 12:08 Paul Feuerstadt also discusses the evolution of treatment for Clostridioides difficile infection, from antimicrobials to recently FDA-approved live biotherapeutics. 15:32 Thomas F. Imperiale, MD, discusses the results of the BLUE-C study, which evaluated the clinical performance of Cologuard, a next-generation, multitarget stool DNA test. 21:08 Read the full coverage here: https://www.healio.com/news/gastroenterology/20231023/video-rebyota-not-only-shuts-down-recurrence-also-affects-quality-of-life-in-c-diff https://www.healio.com/news/gastroenterology/20231025/video-risankizumab-a-great-option-for-patients-induces-clinical-remission-in-uc https://www.healio.com/news/gastroenterology/20231024/video-more-than-75-of-uc-patients-achieve-clinical-response-at-24-weeks-with-tremfya https://www.healio.com/news/gastroenterology/20231025/video-future-is-now-here-for-recurrent-c-difficile-thanks-to-live-biotherapeutics https://www.healio.com/news/gastroenterology/20231025/sensitivity-of-nextgeneration-cologuard-in-precancer-detection-numerically-exceeded-fit Disclosures: Feuerstadt reports financial relationships with Ferring Pharmaceuticals, Regeneron Pharmaceuticals, Seres Therapeutics and Takeda Pharmaceuticals. Imperiale reports grant and research support from Exact Sciences. Loftus reports financial relationships with AbbVie, Alvotech, Amgen, Arena, Avalo Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Exact Sciences, Fresenius Kabi, Genentech, Gilead, GlaxoSmithKline, Gossamer Bio, Iota Biosciences, Iterative Scopes, Janssen, KSL Diagnostics, Lilly, Morphic, Ono Pharma, Pfizer, Protagonist, Receptos, Robarts Clinical Trials, Scipher Medicine, Sun Pharma, Surrozen, Takeda, Theravance and UCB. Wehkamp reports no relevant financial disclosures.
In this episode, we dig through the data of lupus in Africa and speak with experts on the Lupus Gradient, the impact of malaria and what we can learn from it all. · Intro 0:12 · In the previous episode 0:30 · Lupus Gradient 2:01 · Back to Dr. Brian Greenwood 3:48 · Polyarthritis 4:04 · Rates of autoimmune diseases 6:00 · Malaria and mouse models 7:33 · Back to lupus 8:48 · First case of lupus 15:14 · Prevalence of lupus 17:15 · Papers on lupus 21:23 · Dr. Mickael Essouma 23:38 · Dr. Essouma, how did you conduct this study? 24:01 · Did you ever believe there was a gradient? 26:09 · Dr. Sandro Vento 30:56 · Dr. Vento, do you believe there was a lupus gradient? 31:51 · What are the connections to infectious disease? 38:51 · That's a wrap! 43:04 · Coming up in part 4 44:55 · Thanks for listening 45:05 Disclosures: Brown reports no relevant financial disclosures. Healio could not confirm relevant financial disclosures for Essouma and Vento at the time of posting. Mickael Essouma, MD, is physician from Cameroon specialized in internal medicine at the University of Yaounde I in Cameroon, with a complimentary certificate on rheumatology from the EULAR online course and a certificate on lupus from the European Lupus Society (SLEuro). He is an advocate of lupus and other autoimmune diseases in Africans. Sandro Vento, MD, is the dean of faculty of medicine at the University of Puthisastra, Phnom Penh, Cambodia and a consultant and collaborating specialist at Mayo Clinic Center for Tuberculosis, WHO Collaborating Center. We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. References: Bae SC, et al. Arthritis Rheum. 1998;doi:10.1002/1529-0131(199812)41:123.0.CO;2-D. Bryc K, et al. Am J Hum Genet. 2015;doi:10.1016/j.ajhg.2014.11.010. Essouma M, et al. J Autoimmun. 2020;doi:10.1016/j.jaut.2019.102348. Gilkeson GS, et al. Lupus. 2011;doi:10.1177/0961203311404915. Micheletti SJ, et al. Am J Hum Genet. 2020;doi:10.1016/j.ajhg.2020.06.012. Symmons DP. Lupus. 1995;doi:10.1177/096120339500400303. Vento S, et al. Front Med. 2020;doi:10.3389/fmed.2020.00202.
Let's STRETCH this brain meal out, shall we? This week we are separating the entrees into courses with a little trip to the dessert cart! Jeremy serves up the FIRST COURSE today! Keep an eye out for Julie's course this THURSDAY! Let's gobble up the "brain nutrition" that helps YOU feel more empowered to appraise health stories in the news. Today's HEALTH HEADLINES include: Which is safer for athletes, artificial turf, or REAL GRASS playing surfaces? With the recent Achilles injury suffered by Aaron Rodgers on the turf field at the Jets home stadium, the debate between turf vs. grass was reignited, to say the least. What are the pros and cons of turf versus grass fields. What does the data suggest regarding injuries in athletes. Is there any increased risk of cancer to athletes playing on turf fields? Let YOUR DOCTOR FRIENDS give you the digestible chunks of info! PLUS our "Dessert Cart" contains quick bites about a new intra-uterine device (Jada) that can stop postpartum hemorrhage and save lives, as well as "sound colors" and picking what kind of "white noise" can help you! Resources for today's topics include: An ESPN article discussing the turf debate. The NFL Players Association's take on turf. American Journal of Sports Medicine article on injury rates on turf fields. AJSM systematic review on lower extremity injury rates on turf vs grass fields. AJSM article on padded vs non-padded turf fields. British Medical Journal article on concussions and artificial turf. OJSM article on ACL injuries on turf. Safe Healthy Playing Fields Inc website on costs of grass vs turf. Washington State Department of Health investigation of cancer and turf/crumb rubber. Healio article on the RUBY study about the Jada system for treating acute postpartum hemorrhage. Jen Hamilton (labor and delivery RN) viral TikTok about the Jada system. Washington Post article about "sound colors." For more episodes, limited edition merch, or to become a Friend of Your Doctor Friends (and more), follow this link! Also, CHECK OUT AMAZING HEALTH PODCASTS on The Health Podcast Network Find us at: Website: yourdoctorfriendspodcast.com Email: yourdoctorfriendspodcast@gmail.com Call the DOCLINE on 312-380-5005 and leave us a message. We will listen and maybe even respond/play it on the show! (Disclaimer: we will not answer specific medical questions or offer medical advice. Consult your healthcare professional with any and all personal health questions.) Connect with us: @your_doctor_friends (IG) @yourdoctorfriendspodcast1013 (YouTube) @JeremyAllandMD (IG, FB, Twitter) @JuliaBrueneMD (IG) @HealthPodNet (IG)
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Peter Slack, Greg Kunst, Rich Small and Uday Devgan, MD, FACS, FRCS, live from OSN New York. Welcome to the Eyeluminaries podcast :01 Review of episode 18 :18 Intro of Peter Slack 1:47 How did OSN start? 2:35 When did you get into meetings and where do you see meetings going? 5:40 Where do you see media going? 7:46 How did you end up running the Hawaiian Eye Meeting? 10:53 Intro of Greg Kunst 13:59s What will be the biggest challenges introducing a new paradigm for a traditionally surgical disease? 14:52 What can you tell us about Aurion's plans for cell therapy in other front and back of the eye disease, in addition to endothelial cell disease? 17:04 What should I be telling my patients who have future need for endothelial keratoplasty? 19:17 What is the status of Aurion in Japan? Is the competition on the horizon? 22:13 Intro of Rich Small 25:53 Why are you excited about the Encapsulated Cell Therapy Platform? 27:12 Why MacTel? 31:52 What is the status of the Neurotech BLA? 32:26 · Give us a good Jim Mazzo story 34:38 Intro of Uday Devgan, MD, FACS, FRCS(Glasg) 37:05 Tell us about how you got started producing one video per day 38:10 Tell us a story about a doctor from far away who is influenced by your teaching 40:38 If you could change one thing in residency training today, what would it be? 41:59 Preview of episode 20 43:51 Feedback, questions and guest suggestions at eyeluminaries@healio.com 44:04 Uday Devgan, MD, FACS, FRCS(Glasg), is Healio|OSN section editor for Ocular Surgery News. He is in private practice, specializing in cataract and refractive surgery, at Devgan Eye Surgery in Los Angeles and a full partner at Specialty Surgical Center in Beverly Hills, California. He has previously served as full clinical Professor of Ophthalmology at the Jules Stein Eye Institute at the UCLA School of Medicine as well as Chief of Ophthalmology at Olive View-UCLA Medical Center and has been actively involved in resident surgical teaching for over two decades. He owns and operates CataractCoach.com. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Greg Kunst is president, chief executive officer and board member at Aurion Biotech. He is focused in areas such as R&D, clinical development, corporate development, strategy, marketing, commercial, business development, market access and medical affairs with extensive knowledge of global health care markets (North America, Latin America, Europe, Asia), global commercialization and market development, upstream and downstream marketing, market access, and medical affairs for medical device, drug delivery systems, diagnostic systems, biotechnology, cell therapies, gene therapies, biologics, and pharmaceutical products. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Peter N. Slack is president and chief executive officer of The Wyanoke Group. Peter is past-Chairman and a current member of the Board of Trustees for the Center for Family Services, a nonprofit human services agency. Other professional titles and memberships have included Board of Directors of the International Association of Association Management Companies and Board of Directors of the American Medical Publishers Association. In addition, Peter is President of the Broadway Theatre of Pitman in Pitman, NJ. Disclosure: The Wyanoke Group is the holding company for Healio, the producer of the Eyeluminaries podcast. Rich Small is chief executive officer and member of the board of directors for Neurotech. He originally joined Neurotech in July 2007 as the company's chief financial officer. He has in excess of 30 years of both private and public life sciences experience and more than 40 years of overall financial and operational management. Previously Rich served as Senior Vice President and Chief Financial Officer of Point Therapeutics, a publicly traded biotechnology company focused in developing treatments for various cancers. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Devgan owns and operates CataractCoach.com. Hovanesian consults widely in the ophthalmic field. Kunst is president, chief executive officer and board member at Aurion Biotech. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Slack is president and chief executive officer of The Wyanoke Group. Small is chief executive officer and member of the board of directors for Neurotech. The Wyanoke Group is the holding company for Healio, the producer of the Eyeluminaries podcast.
This week you get TWO entrees with a little trip to the dessert cart! Julie and Jeremy picked some juicy stories from health headlines, strained out the inedible parts, and left you the sweet nectar. Let's gobble up the "brain nutrition" that helps YOU feel more empowered to appraise health stories in the news. This week's HEALTH HEADLINES include:Why do women pay more out-of-pocket for healthcare in the US? Julie breaks down a Deloitte analysis, and teaches Jeremy about the PINK TAX, and how it's EVERYWHERE (including in our insurance healthcare costs).Do LED light masks actually work? Do they result in younger-looking skin, less wrinkles, and fewer acne breakouts? Or are they just a scary cross-between-Jason-and-Ironman looking facial accessory??Our "Dessert Cart" contains quick bites about blood tests for long COVID, expiration dates for COVID tests, and cannabis-related car crashes and ER visits. Resources for today's topics include:Deloitte's analysis- "Hiding in plain sight: The health care gender toll." The CDC's Summary Health Statistics: National Health Interview Survey 2018.A 2019 Harvard Health Article- "Mars vs Venus: The gender gap in health."The Hysteria Podcast on Crooked Media (Sept 28 Episode features the Deloitte Analysis)(lol not scientific, but funny) A HuffPo Listicle about THE PINK TAX.American Society of Plastic Surgeons website on "What is LED light therapy and what are the benefits?"Harvard Health Article- "LED lights: Are they a cure for your skin woes?"Annals of Family Medicine article- "Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis".Cochrane Database of Systematic Reviews- "Light therapies for acne."An article from Photomedicine and Laser Surgery on red-light therapy for facial skin. A Healthline article- "LED Light Therapy for Skin: What to Know."Healio article- "Traffic injury ED visits involving cannabis grow over recent years."For more episodes, limited edition merch, or to become a Friend of Your Doctor Friends (and more), follow
Welcome back to You Had Me At Eat season 2. Jules and Erica had a quick break while Jules moved her youngest with a specialty diet into the college dorms! Jules and Erica also took a trip to Tucson, Arizona where they explored Erica's favorite gluten-free bakery, and visited the Desert Sonoran Museum in 107 degrees. You Had Me At Eat is also nominated for Best Gluten-Free Podcast in the Gluten-Free Buyers' Guide Gluten-Free Awards for 2024, and Erica was nominated for the Patient Voice award for the Healio Gastroenterology Disruptive Innovators award! Listen in and welcome back!RESOURCES:Spokin Food-Allergy-Friendly CollegesGluten-Free in College by gfJulesDedicated gluten-free bakery in Tucson, AZGluten-Free Buyers Guide gluten-free awards 2024 - be sure to vote for Erica for best gluten-free personality, gfJules for everything else, and You Had Me At Eat podcast!Healio Gastroenterology Disruptive Innovator award - Erica was nominated!Contact/Follow Jules & Erica Tweet us @THEgfJules & @CeliacBeast Find us on IG @CeliacandTheBeast & @gfJules Follow us on FB @gfJules & @CeliacandTheBeast Email us at support@gfJules.com Find more articles, recipes & info at gfJules.com & celiacandthebeast.com Thanks for listening! Be sure to subscribe!**some links may be affiliate links; purchasing through these links will not cost you more, but will help to fund the podcast you ❤️
In this episode, hosts Shikha Jain, MD, Douglas H. Jones, MD, Amy Comander, MD, Dagny Zhu, MD, Don Dizon, MD, and Mark A. Lewis, MD, discuss the new social media platform, Threads and how physicians can use it for their practice. • Welcome to another exciting episode of Oncology Overdrive :57 • The topic 1:10 • How many have created a profile on Threads? Why or why not? 2:59 • Dr. Jain has a Thread profile but is unsure how to get more engagement 3:20 • Dr. Lewis has convinced coworkers to use social media but has not used Threads yet 4:54 • Dr. Dizon has a Thread profile but notes that leaving other platforms is leaving those communities and starting all over on a new platform 6:25 • Giving Threads more time to pick up followers and engagement 11:18 • Dr. Zhu has a Thread profile and found it easy to create but engagement is not the same as other platforms 12:17 • Tips and tricks to sharing content on socials, especially Threads 14:33 • Trouble with other social media platforms 17:55 • Tips and tricks to building a community on a social media 20:20 • The power of social media platforms and engagement in established communities 22:30 • Fighting misinformation 25:13 • Platforms versus audience 27:15 • How would you like to see Threads change as a platform? 31:21 • What is the power of TikTok in terms of getting movement among communities? 33:31 • How do you create a profile on Threads? 40:30 • Level of engagement: Twitter vs. Threads 43:31 • The overwhelming number of platforms 52:29 • What is the best platform for physicians to use? 53:41 • Sharable content to post across other platforms 55:34 • Final thoughts 58:09 • Thanks for listening 1:02:13 Douglas H. Jones, MD, is the cofounder of Global Food Therapy, cofounder and president of Food Allergy Support Team and director of Rocky Mountain Allergy at Tanner Clinic. You can follow him on Threads @drdouglasjones. Amy Comander, MD, DipABLM, is director of breast oncology and survivorship at the Massachusetts General Hospital Cancer Center in Waltham and at Newton-Wellesley, and medical director of the Massachusetts General Hospital Cancer Center in Waltham. She is director of the Lifestyle Medicine Program at the Massachusetts General Hospital Cancer Center. She is also an instructor in medicine at Harvard Medical School. You can follow her on Threads @dramycomander. Shika Jain, MD, FACP, is an associate professor of medicine with tenure in the division of hematology, oncology and cell therapy at the University of Illinois Cancer Center in Chicago. She is the director of communication strategies in medicine and associate director of oncology communication and digital innovation. She also is consulting editor for Healio Women in Oncology, as well as host of Healio's Oncology Overdrive podcast. You can follow her on Threads @shikajainmd. Dagny Zhu, MD, is a cornea, cataract, and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. You can follow her on Threads @dzeyemd. Don S. Dizon, MD, FACP, FASCO, is head of community outreach and engagement at the Cancer Center at Brown University and head of the breast and pelvic malignancies program at Lifespan Cancer Institute. You can follow him on Twitter (X) and TikTok @drdonsdizon. Mark A. Lewis, MD, is the director of gastrointestinal oncology at Intermountain Healthcare in Murray, Utah, and a medical oncologist specializing in cancers of the gastrointestinal tract and accessory organs. You can follow him on Twitter (X) @marklewismd. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on Twitter and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on Twitter: @ShikhaJainMD. Disclosures: The moderators and panelists report no relevant financial disclosures.
Laura B. Enyedi, MD, and Dagny Zhu, MD, discuss contract negotiations and the gender wage-gap in ophthalmology with Lisa Nijm, MD, JD. · Welcome to another episode of Mend the Gap :01 · The topic :45 · Introduction Lisa Nijm, MD, JD 1:10 · What are the most important parts of contract negotiation? 4:20 · What are the items that are the most important to negotiate? 6:09 · Do you find a middle ground when it comes to negotiations? 11:04 · Receiving backlash for being “too aggressive” in negotiations 15:05 · Approaching negotiations with confidence 19:17 · Gender pay-gaps 20:14 · Women physicians and inequality 27:52 · For more information, go to realworldophthalmology.com and wioonline.org 31:50 · Thank you 33:20 We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Laura B. Enyedi, MD, is professor of ophthalmology and pediatrics at Duke Eye Center and medical director of South Durham Ophthalmology in North Carolina. Lisa Nijm, MD, JD, is a cornea, cataract and LASIK surgeon at Warrenville Eyecare & LASIK, licensed attorney, innovator and assistant professor at the University of Illinois Eye & Ear Infirmary. Dagny Zhu, MD, is a cornea, cataract, and refractive surgeon and medical director and partner at NVISION Eye Centers in Rowland Heights, CA. She can be reached on twitter @DZEyeMD. Disclosures: Enyedi and Zhu report no relevant financial disclosures. Healio could not confirm relevant financial disclosures for Nijm at the time of posting.
In this episode of Meeting Mic, we bring you Healio's top headlines from DDW 2023. Jessica R. Allegretti, MD, MPH, reviews the results of a Tremfya study presented at the meeting. :09 Ken Blount, PhD, discusses restoration of gut microbiota and clonal engraftment after treatment with Rebyota. 4:07 Evan S. Dellon, MD, MPH, explains the improvements of mepolizumab seen in patients with eosinophilic esophagitis. 10:50 Jessica R. Allegretti also discusses the treatment with Rebyota in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection. 15:16 Shrujal Baxi, MD, MPH, describes the use of artificial intelligence for polyp detection for colorectal cancer. 19:26 Paul Limburg, MD, MPH, AGAF, reviews the revised guidelines and the push for non-invasive screening methods for colorectal cancer. 24:07 Read the full coverage here: https://www.healio.com/news/gastroenterology/20230509/video-patients-with-uc-achieve-symptomatic-remission-as-early-as-week-4-with-tremfya https://www.healio.com/news/gastroenterology/20230509/video-distinctive-shift-in-gut-microbiota-after-rebyota-treatment-for-c-difficile https://www.healio.com/news/gastroenterology/20230510/video-mepolizumab-for-eoe-does-not-yield-prominent-symptom-improvement-after-6-months https://www.healio.com/news/gastroenterology/20230509/video-no-change-in-concomitant-medications-after-rebyota-for-recurrent-c-difficile-ibd
This week on Pharm5 Humira biosimilars Vyvanse, Symbicort, and more losing patents this year Rezafungin approval Senate Committee meets on drug shortages COVID-19 declassified Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Sandoz receives US FDA approval for biosimilar Hyrimoz® (Adalimumab-adaz) high-concentration formulation. Novartis. http://bit.ly/3lBJ1rK. Published March 21, 2023. Accessed March 23, 2023. Humira [package insert].North Chicago, IL: AbbVie Inc. Accessed March 23, 2023. Stonehill M. Humira exclusivity expires in 2023: Will biosimilar boom benefit patients or industry? Healio. http://bit.ly/3lzQrvs. Published January 17, 2023. Accessed March 23, 2023. Amjevita™ (Adalimumab-Atto), first biosimilar to Humira®, now available in the United States. Amgen. http://bit.ly/3Z9gesm. Accessed March 23, 2023. Kansteiner F, Sagonowsky E, Becker Z, Dunleavy K, Liu A. The top 10 drugs losing us exclusivity in 2023. Fierce Pharma. https://bit.ly/3LGsm0N. Published March 13, 2023. Accessed March 23, 2023. FDA drug shortages. FDA Drug Shortages. http://bit.ly/3LLEAoY. Accessed March 23, 2023. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2022. www.ginasthma.org. Accessed March 23, 2023. Cidara Therapeutics, Inc. Cidara Therapeutics and Melinta Therapeutics announce FDA approval of Rezzayo™ (rezafungin for injection) for the treatment of Candidemia and invasive candidiasis. GlobeNewswire News Room. http://bit.ly/40utHMl. Published March 22, 2023. Accessed March 23, 2023. Thompson GR, Soriano A, Cornely OA, et al. Rezafungin versus Caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): A multicentre, double-blind, double-dummy, randomised phase 3 trial. The Lancet. 2023;401(10370):49-59. doi:10.1016/s0140-6736(22)02324-8 FDA Approves Rezzayo, a Novel Echinocandin. Infectious Disease Special Edition. https://bit.ly/3TAbn2d. Published March 23, 2023. Accessed March 23, 2023. Gauthier T. Rezafungin (Rezzayo). IDStewardship. http://bit.ly/3LHBn9X. Accessed March 23, 2023. O'Mary L. Cases of potentially deadly fungus jump 200%: CDC. Medscape. http://bit.ly/40lSRwC. Published March 22, 2023. Accessed March 23, 2023. Drug shortage health and national security risks: Underlying causes and needed reforms. Committee on Homeland Security & Governmental Affairs. https://bit.ly/3ZdX846. Published March 22, 2023. Accessed March 23, 2023. Biden signs Bill on COVID origins declassification. AP NEWS. http://bit.ly/3JCsOKJ. Published March 20, 2023. Accessed March 23, 2023. Pradhan R. End of Covid emergency will usher in changes across the US Health System. Kaiser Health News. http://bit.ly/40xC0H0. Published March 22, 2023. Accessed March 23, 2023.
In this conversation, Daniel Belkin and Mitch Belkin interview Adam J Brown, MD about the field of Rheumatology, autoimmune diseases, and his podcast Rheuminations. They discuss the history of gout, plaquenil, the relationship between infectious diseases and rheumatologic conditions, the inflammasome, autoinflammatory disorders, vasculitis, fibromyalgia, Covid, and much more.Who is Adam J Brown?Dr. Adam J. Brown is a Rheumatologist at the Cleveland Clinic. Dr. Brown is the author of the book Rheumatology Made Ridiculously Simple. He is also the host of the Healio podcast Rheuminations, which focuses on autoimmunity, rare diseases, and the history of medicine. References:Twitter - @AdamJBrownMDAdam J Brown's Quiz Platform Rheum and BoardsHealio Rheuminations Podcast Support the showFollow us at @ExMedPod Subscribe to our Youtube channelConsider supporting us on Patreon
Susan Weiner SPEAKER | AUTHOR MS | RDN | CDCES | FADCES Susan Weiner is an award-winning nutrition, health and diabetes expert and the owner of Susan Weiner Nutrition, PLLC. Susan served as the 2015 ADCES Diabetes Educator of the Year and is an ADCES fellow. Among her many distinguished awards, she is the recipient of the 2019 Metropolitan New York Association of Diabetes Educators Advocate of the Year Award and the 2018 Media Excellence Award from the New York State Academy of Nutrition and Dietetics. Susan is the “Diabetes in Real Life” columnist for Endocrine Today and is the on-air host for video interviews and content for Healio.com. She is the co-author of The Complete Diabetes Organizer: Your Guide to a Less Stressful and More Manageable Diabetes Life and Diabetes: 365 Tips for Living Well. Susan has extensive TV, radio, podcast and video experience and is well versed in media communications. Susan is a well-respected national and international speaker on a variety of topics related to nutrition, diabetes, wellness and health, and has authored dozens of articles in peer reviewed journals. She has authored and been cited in over 300 articles for popular press, consumer publications and online sites. Susan earned her Master's Degree in Applied Physiology and Nutrition from Columbia University. Susan Weiner, MS RDN CDCES FADCES Owner and Clinical Director, Susan Weiner Nutrition PLLC 2015 ADCES Diabetes Educator of the Year Diabetes In Real Life columnist, Endocrine Today New Website! www.susanweinernutrition.com - @susangweiner The Happy Diabetic Kitchen Podcast is sponsored by US MED Please visit https://www.usmed.com/happydiabetic/ today for a free benefits check US MED WELCOMES THE HAPPY DIABETIC COMMUNITY When it comes to your health, nothing else matters. That's why with US MED, your health matters to us. From insulin pumps, continuous glucose monitors, blood glucose strips and more, your well-being is in the right hands with the experts at US MED. Call Us : 888-885-0012
In this episode, host Shikha Jain, MD, speaks with Michael Roizen, MD, author and chief wellness officer at the Cleveland Clinic, about developing tools that can help lead to a longer life, public health messaging in media and more. Welcome to another exciting episode of Oncology Overdrive :14 About Roizen :20 The interview 1:01 How did you get to where you are today, and what was your journey into medicine, health care and everything you are doing outside of clinical medicine? 1:30 How do we de-age ourselves, and what do we do to reboot ourselves? 4:30 Why have we not had a national movement toward this when this is something that many people care so much about? 9:39 Jain and Roizen on retirement age, life expectancy and medical benefits 11:38 Do you think there are any modifications or anything we should think about differently now that COVID is a part of our everyday life? 17:34 What are you covering in this book [The Great Age Reboot: Cracking the Longevity Code for a Younger Tomorrow]? What is its purpose? 19:43 For those of us who are parents, does it matter if you start programming cells from a young age, or is this more for adults? 22:50 How did you get an Emmy? 27:12 What do you think of how communication to the public has changed? … What do you think about where we are going and how things have evolved over the years? 29:08 What's next for you? … How do you find the time to do all of this? 32:38 About Jain's non-profits and Roizen's involvement in gender equity movements in medicine 38:09 If someone could only listen to the last minute of this episode, what would you want them to take away? 44:14 How to contact Roizen and get his book 45:03 Thanks for listening 46:16 Michael F. Roizen, MD, is the emeritus chief wellness officer at the Cleveland Clinic, a professor at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, and author of four #1 New York Times best-selling books. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Roizen can be reached via email at info@greatagereboot.com, or on the website GreatAgeReboot.com. Find The Great Age Reboot: Cracking the Longevity Code for a Younger Tomorrow wherever you get your books! Disclosures: Jain reports no relevant financial disclosures. Healio could not confirm Roizen's financial disclosures at the time of publication.
It's in the News.. the top diabetes stories of the past seven days. This week, the first drug to prevent T1D for any length of time is approved, Eli Lilly takes a financial hit from a Twitter impersonation stunt, Medtronic's 7-day pump infusion set is ready for consumers, Dexcom's G7 gets great reviews from older folks and educators for ease of use, a new study about light at night and diabetes and more! Learn more about the T1D Exchange: www.t1dexchange.com/stacey Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. XX In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population. https://t1dexchange.org/stacey/ XX And by my new book “Still The World's Worst Diabetes Mom: More Real Life Stories of Parenting a Child With Type 1 Diabetes” available on Amazon in paperback and for kindle. XX Our top story this week, the US U.S. Food and Drug Administration approves teplizumab, the first drug to delay the onset of type 1 diabets. We've been following this for a long time and I'll ink up our previous interviews with Provention Bio, the company that makes it. The brand name will be Tzield (teplizumab-mzwv) and it's an injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes. Tzield is administered by intravenous infusion once daily for 14 consecutive days. Lots of questions here and we'll follow up with an interview and more as soon as I can. https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-can-delay-onset-type-1-diabetes https://diabetes-connections.com/delaying-a-t1d-diagnosis-the-fda-considers-teplizumab/ XX Our top story this week – the kerfuffle over on Twitter where a couple of accounts spoofed Ely Lilly. The insulin makers stock tanked 6% over just one day late last week, wiping billions of dollars from its market cap. On Nov.10, someone pretending to be Lilly's corporate account tweeted: “We are excited to announced insulin is free now.” You may know that Twitter under new owner Elon Musk was verifying any account with any name for just 8-dollars. Another verified but fake Lilly account tweeted profanities and taunted people who use insulin with higher pricing, again, also fake. Other major insulin makers Sanofi and Novo Nordisk were also caught up in the crossfire, with their stock prices dipping and questions over the high cost of insulin back in the headlines. In the understatement of the year, Lilly CEO David Ricks said – quote – “it probably highlights that we have more work to do to bring down the cost of insulin for more people” XX Mice with diabetes appeared cured after transplantation of insulin-secreting pancreatic islet cells, according to a Stanford Medicine study. The animals' immune systems were coaxed to accept the donated cells prior to transplantation through a three-pronged process that could be easily replicated in humans, the researchers said. No immune-suppressing treatments were necessary after the transplant to prevent rejection of the foreign islet cells. The technique, which builds on earlier work at Stanford Medicine, may open the door to a new type of organ transplant that doesn't require an immunologically matched donor or years on immune-suppressing medication. The difference here is that they do two transplants.. first doing a partial blood stem cell transplant which makes the new pancreas cells recognized as the body's own and less likely to be rejected. Long way to go here, but promising idea. https://med.stanford.edu/news/all-news/2022/11/islet-transplant-diabetes.html XX The first and only 7-day infusion set is ready to go.. after approval more than a year ago – in September of 2021, Medtronic says customers can now order the Medtronic Extended for the 600 and 700 series pumps. In clinical studies of the Medtronic Extended infusion set, study participants observed a decrease in the number of times an infusion set needed to be changed by 50% and the number of infusion set failures associated with high glucose levels was lowered.3,4 Study participants using the Medtronic Extended infusion set commented on the new infusion set being more comfortable to wear compared to their previous infusion sets and were happy with the longer wear feature in helping reduce the overall burden of insulin pump therapy.3,4 Additionally, use of the Medtronic Extended infusion set is estimated to result in annual costs savings of insulin of up to 25% due to a reduced number of infusion set and reservoir changes that result in unrecoverable insulin, as well as plastic waste reduction of up to 50%. https://www.prnewswire.com/news-releases/medtronic-launches-worlds-first-and-only-infusion-set-for-insulin-pumps-that-doubles-wear-time-up-to-7-days-in-us-301677790.html XX Recall for omnipod. This is an issue with the Omnipod 5 Controller charging port and cable. This does not impact the Omnipod 5 Pod, the Omnipod® DASH Insulin Management System, the Omnipod® Insulin Management System, or compatible Android smartphone devices that have the Omnipod 5 App installed. No serious injuries have been reported, but insulet has received reports tht the omnipod 5 controller chargting port or cable is discoloring or even melting due to excess heat. Customers are instructed to called insulet or login to an fda site. I'll link up all of that info in the show notes. at 1-800-6). Additional informati41-2049, which is available 24 hours a day, 7 days a week. Alternatively, Omnipod 5 users can utilize the FDA's MedWatch Adverse Event Reporting program either online (www.fda.gov/medwatch/report.htmExternal Link Disclaimer), by regular mail, or by fax (1-800-FDA-0178on, including instructions to customers to mitigate risk, can be found on the Company's website at www.omnipod.com/insulet-alertsExternal Link Disclaimer. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/insulet-issues-nationwide-voluntary-medical-device-correction-omnipodr-5-controller XX Small study shows that using the Dexcom G7 is easier for older adults to insert and use. Results indicate that G7 CGM system required half as many steps to set up and deploy as the G6 system, with the system's system usability scale survey scores indicating excellent usability. The current study was launched to better understand ease of use and task burden of uptake of Dexcom's G7 CGM system. To do so, investigators designed their study as a formal task analysis with the intent of identifying the number and complexity of tasks associated with deployment of the G7 CGM system compared to the fifth- and sixth-generation systems in adults aged 65 years or older. A cohort of 10 older adults with no prior CGM experience and 10 CDCESs were recruited for inclusion in the investigators' formal task analysis. This analysis assessed ease of use among CDCESs through a survey after hands-on insertion and initiation of the system. For older adults in the study, ease of use was assessed using system usability scale (SUS) survey scores. In the post-test survey and SUS survey given to older adults, no responses lower than neutral were recorded and the SUS score for setup and insertion of the G7 system was 92.8, which investigators noted was reflective of an excellent usability rating. https://www.endocrinologynetwork.com/view/study-finds-dexcom-g7-set-up-is-easier-requires-fewer-tasks-for-older-adults-than-previous-generations XX Control IQ for people with type 2 works well and is safe. New study from Tandem Diabetes Care shows people with type 2 spent 3.6 hours a day long in target range after switching to the tslim x2 pump / Dexcom system from multiple daily injections or basal insulin only https://www.medtechdive.com/news/tandem-pump-dexcom-CGM-Type-2-diabetes/636448/ XX New program from Walgreens to help give more people access to information and diabetes services. Walgreens is teaming up with its Health Corners and third-party clinics to offer free A1C and blood glucose testing and diabetes education during November, Diabetes Awareness Month. For participating locations, visit Walgreens.com/FreeDiabetesScreening and I'll link that up. Walgreen is the largest provider of continuous glucose monitors including the Dexcom G6 and FreeStyle Libre 2 which track glucose levels all day and night – fewer finger sticks required. 7. Affordable care options and tools including Walgreens Prescription Savings Club and Find Rx Coverage which offer insulin savings programs and affordable, predictable copayments on select insulins. Walgreens Find Care provides access to in-person and virtual healthcare expertise from the comfort of one's home. XX Sleeping in a room exposed to outdoor artificial light at night may increase the risk of developing diabetes, according to a huge study of nearly 100,000 Chinese adults. People who lived in areas of China with high light pollution at night were about 28% more likely to develop diabetes than people who lived in the least polluted areas. We told you about a study published earlier this year that showed Sleeping for only one night with a dim light, such as a TV set with the sound off, raised the blood sugar and heart rate of the young people during the sleep lab experiment. These researchers caution that any direct link between diabetes and nighttime light pollution is still unclear, however, because living in an urban area is itself a known contributor to the development of diabetes https://www.cnn.com/2022/11/14/health/night-light-pollution-diabetes-sleep-wellness/index.html XX Researchers are recruiting 20,000 children for a trial to try to identify those at high risk of developing type 1 diabetes. If left undiagnosed or untreated, the condition can lead to life-threatening complications. The trial, led by the University of Birmingham, could mean access to new treatments for children at high risk. The researchers say it may also offer insights that could make screening for type 1 diabetes a possibility. ADVERTISEMENT Type 1 diabetes is an autoimmune condition where the immune system attacks and destroys cells in the pancreas which produce insulin. Insulin is crucial because it moves energy from food from the blood to the cells of the body - without it, the body cannot function properly. Approximately 29,000 children in the UK currently have type 1 diabetes, out of a total of about 400,000 people. For them, managing the condition involves injecting insulin and testing blood glucose levels regularly. The condition is very different to type 2 diabetes, which is often linked to poor diet or an unhealthy lifestyle. The organisers want children aged three to 13 to sign up for the trial, which will analyse their blood - through finger prick and vein tests - for autoantibodies. These are linked to the development of type 1 diabetes. Those with two or more autoantibodies have an 85% chance of having the condition within 15 years, and are almost certain to develop it in their lifetime. 'A simple test could have saved my son' Parth Narendran, professor of diabetes medicine, and Dr Lauren Quinn, clinical research fellow at the University of Birmingham, said there was a need to explore if screening children for type 1 diabetes in the UK would be possible in the UK. "Screening children can reduce their risk of DKA (diabetic ketoacidosis) at diagnosis around fivefold and can help them and their families settle into the type 1 diagnosis better," they said. DKA is a life-threatening complication of type 1 which can occur when diagnosis does not happen quickly. Rachel Connor, director of research partnerships at JDRF UK, which is co-funding the study, said new drugs that target the immune system were progressing through trials. "We are demonstrating that it is possible to delay the need for intensive insulin treatment in those most at risk. When these drugs become available in the UK, we need to be ready to use them straight away," she said. Dr Elizabeth Robertson, from Diabetes UK, which also funded the study, said: "Extra years without the condition means a childhood no longer lived on a knife-edge of blood sugar checks and insulin injections, free from the relentlessness and emotional burden of type 1 diabetes." https://www.bbc.com/news/health-63622084 XX New study on pancreas transplants. These researchers say Up to 90% of people who received a pancreas transplant enjoy freedom from insulin therapy and the need for close glucose monitoring. Biggest drawback is having to take immunosuppressants for the rest of their life. The number of pancreas transplants has declined in recent years. New paper this week in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism. Another downside is that this isn't a long-term cure.. the paper says the median graft survival is around eight years and the transplanted pancreas does not always work well, so the patient might not be completely insulin-free. However, I do believe that the combined kidney/pancreas transplant should be considered for all patients with type 1 diabetes with an indication for a kidney transplant.” https://www.healthline.com/health-news/type-1-diabetes-the-benefits-and-limitations-of-a-pancreas-transplant XX Medtrnoic sending emails out regarding the CareLink™ Software outages. . For most of our customers, we were able to resolve the issue relatively quickly through an application fix that took effect when individuals logged out and then logged back into their CareLink™ accounts (reminder of these recommended actions available here). But we know this was not the experience for all, and for some of you the experience was extremely frustrating and lasted longer. Medtnoic is still working to resolve the issue for some customers. They stress this was not because of a security breach but don't give further details. https://app.medtronicdib.mdtpatient.com/e/es?s=357929245&e=822474&elqTrackId=b0ce7494b5bd47ad9b9c672c71086a1c&elq=3155b86a3ca045f0a2e27c182f392387&elqaid=7514&elqat=1&fbclid=IwAR1XYIdfEFpkUrdk-yTk6WKSvlsdncJBNrSy_OpdeuJhHXD2zi78WnxaSG8 XX Women with polycystic ovary syndrome (PCOS) were found to be at higher risk for developing type 2 diabetes over a 30-year period, according to new research presented at the 2022 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo, and described in an article at Healio. PCOS is a hormonal disorder that causes enlarged ovaries containing small fluid-filled sacs, and it can have painful symptoms. Hormonal changes related to PCOS can also have effects throughout the body — including effects related to diabetes. One study estimated that nearly one in five adolescent girls with type 2 diabetes also has PCOS, although the nature of the link between PCOS and diabetes is still not fully understood. Many scientists believe, though, that insulin resistance — when tissues in the body become less sensitive to insulin, which is a large part of the disease process in type 2 diabetes — also plays a role in the development of PCOS. There is also evidence that correcting the hormonal imbalances seen in PCOS may reduce the risk of developing type 2 diabetes. A recent study showed that taking oral birth control pills as a treatment for PCOS reduced the risk for type 2 diabetes. https://www.diabetesselfmanagement.com/news-research/2022/11/16/polycystic-ovary-syndrome-linked-to-higher-risk-for-type-2-diabetes/ XX XX Back to the news in a moment but first.. The T1D Exchange Registry is a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. The platform is open to both adults and children with T1D living in the U.S. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. The registry aims to improve knowledge of T1D, accelerate the discovery and development of new treatments and technologies, and generate evidence to support policy or insurance changes that help the T1D community. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy. The registry is now available on the T1D Exchange website and is simple to navigate, mobile and user-friendly. For more information or to register, go to www.t1dregistry.org/stacey XX SAFE TRAVELS to all en route to San Francisco for the Fall 2022 #Diabetes Mine #Innovation Days. Can't wait to see u all in person! Nov 17 and 18 XX XX On the podcast next week.. My daughter Lea talks about siblings and type 1. Last week was all about Eversense E3 and the future of long-term CGM sensors. Listen wherever you get your podcasts That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.
In this episode, Eleonora Teplinsky, MD, discusses the evolution of advocacy in the health care space, the challenges cancer patients face after the overturning of Roe v. Wade, and more. Disclaimer: The views and opinions expressed in this episode are those of the speakers and do not necessarily reflect the views or positions of Healio. Welcome to another exciting episode of Oncology Overdrive :13 About Teplinsky :17 The interview: 1:07 How did you decide to do breast oncology, and how did you decide to incorporate advocacy into that space? 1:38 Have you seen an evolution in health care “advocacy”… and has it evolved over the years in how we engage in it? 4:47 Can you talk a little bit about these types of policy changes, how they're going to impact our patients? 8:59 How on earth could we say, “This is a medical emergency” and not be prosecuted for terminating the pregnancy in some of these states? 14:41 How can we call ourselves innovative, and forward-thinking, and breaking edge technology in health care and then make decisions that put us back hundreds of years? 16:32 What do we suggest to our colleagues, and patients, in these states if they find themselves in this situation? 20:37 When there is such massive disapproval for the reversal of Roe v. Wade, how do we move forward, and how do we make this change? 27:02 What do you do to keep pushing forward? How do you keep yourself engaged and motivated to try and make changes when it feels like nothing you're doing is actually making a difference? 27:59 Have you ever had a situation where somebody has come up to you in real life and said, “I didn't like what you put on social media”? Has a patient recognized you in a positive or negative way from something that you put out into the ethos of social media or beyond? 29:48 Let's say you had a magic wand, and you could wave it and make things exactly the way you want. What do you think needs to be done, specifically for the Roe v. Wade situation? … What would you think would be the best way to move forward? 32:43 If someone could only listen to the last 30 seconds of this podcast, what would you want them to take away? 34:37 How to contact Teplinsky 35:15 Thanks for listening 36:02 Eleonora Teplinsky, MD, is head of breast medical oncology at Valley-Mount Sinai Comprehensive Cancer Care; clinical assistant professor of medicine at The Icahn School of Medicine at Mount Sinai. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Teplinsky can be reached @drteplinsky on Twitter and Instagram, or at drteplinksy.com. Disclosures: Jain reports she is a paid freelance writer for Lippincott. Teplinsky reports no relevant financial disclosures.
This week on Pharm5: AAPI patients underrepresented in clinical trials Camzyos (mavacamten) approved for obstructive HCM Voquenza (combination vonoprazan products) approved for H. pylori Pharmacy job postings up 18% in 2021 Implications of potential overturn of Roe v. Wade References: Asian, Indigenous, Latino patients underrepresented in US clinical trials of Biologics. Healio. https://www.healio.com/news/rheumatology/20211208/asian-indigenous-latino-patients-underrepresented-in-us-clinical-trials-of-biologics#:~:text=Asian%2C%20American%20Indian%2C%20Alaska%20Native,research%20letter%20published%20in%20JAMA. Accessed May 5, 2022. Camzyos Prescribing Information. accessdata.fda.gov. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214998. Accessed May 5, 2022. Cosdon N. FDA approves 2 vonoprazan treatments for helicobacter pylori infection. Contagion Live. https://www.contagionlive.com/view/fda-approves-2-vonoprazan-treatments-for-helicobacter-pylori-infection. Published May 3, 2022. Accessed May 5, 2022. Staff PT. FDA approves pair of Vonoprazan treatments for helicobacter pylori infection. Pharmacy Times. https://www.pharmacytimes.com/view/fda-approves-pair-of-vonoprazan-treatments-for-helicobacter-pylori-infection. Published May 4, 2022. Accessed May 5, 2022. Pharmacy Demand Report (PDR) 2021 Yearly Summary - aacp.org. https://www.aacp.org/sites/default/files/2022-04/pdr-2021-yearly-summary.pdf. Accessed May 5, 2022. Roe v. Wade live updates: Protests rage on over leaked abortion ruling. NBCNews.com. https://www.nbcnews.com/news/us-news/live-blog/roe-v-wade-live-updates-protests-rage-leaked-abortion-ruling-rcna27427. Published May 5, 2022. Accessed May 5, 2022.
Meeting the needs of cancer program staff to ultimately improve patient outcomes is at the heart of the presidential themes of ACCC's current and immediate past presidents. CANCER BUZZ spoke to Krista Nelson, who advocated for the professional well-being of cancer program staff and Dr. David Penberthy, who aims to leverage technology to transform cancer care delivery and the patient experience. Hear how both tenures focus on what's most important in the cancer care community—supporting patients, clinicians, and staff. Krista Nelson, MSW, LCSW, OSW-C, FAOSWACCC 2021-2022 PresidentProgram Manager of Quality & Research, Cancer Support Services & CompassionProvidence Cancer InstitutePortland, OR David R. Penberthy, MD, MBAACCC 2022-23 PresidentMedical Director, Radiation Oncology, Bon Secours, Southside Regional Medical CenterPetersburg, VAResources: Krista Nelson's President's Theme 2021-22, "Real-World Lessons from COVID-19: Driving Oncology Care Forward.” Dr. David R. Penberthy's President's Theme 2022-23, “Leveraging Technology to Transform Cancer Care Delivery and the Patient Experience.” Making the Case for New Staff demonstrate the justification for hiring oncology supportive care staff.Mindfulness Meditations help members of the cancer care team better manage stress and improve their overall well-being.[MINI-PODCAST] Ep 74: The Business Case for Hiring Oncology Social Workers[Video] Dr. David R. Penberthy on Looking AheadNew Association of Community Cancer Centers president looks to technology-driven solutions, article from Healio.com[ACCCBuzz Blog] Recap: ACCC's 48th Annual Meeting and Cancer Center Business Summit Part 1 and Part 2
© 2020-2026 Ivy Podcast Discovery LLC
